US5827277A - Minimally invasive apparatus for internal ablation of turbinates - Google Patents

Minimally invasive apparatus for internal ablation of turbinates Download PDF

Info

Publication number
US5827277A
US5827277A US08/790,081 US79008197A US5827277A US 5827277 A US5827277 A US 5827277A US 79008197 A US79008197 A US 79008197A US 5827277 A US5827277 A US 5827277A
Authority
US
United States
Prior art keywords
energy
delivering
nasal
catheter
probes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US08/790,081
Inventor
Stuart D. Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somnus Medical Technologies Inc
Original Assignee
Somnus Medical Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/265,459 external-priority patent/US5505730A/en
Priority claimed from US08/752,076 external-priority patent/US5800429A/en
Application filed by Somnus Medical Technologies Inc filed Critical Somnus Medical Technologies Inc
Priority to US08/790,173 priority Critical patent/US5843077A/en
Priority to US08/790,081 priority patent/US5827277A/en
Priority to AU32040/97A priority patent/AU3204097A/en
Priority to PCT/US1997/007818 priority patent/WO1997043971A2/en
Assigned to SOMNUS MEDICAL TECHNOLOGIES, INC. reassignment SOMNUS MEDICAL TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EDWARDS, STUART D.
Application granted granted Critical
Publication of US5827277A publication Critical patent/US5827277A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1477Needle-like probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/148Probes or electrodes therefor having a short, rigid shaft for accessing the inner body transcutaneously, e.g. for neurosurgery or arthroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1485Probes or electrodes therefor having a short rigid shaft for accessing the inner body through natural openings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0475Tracheal tubes having openings in the tube
    • A61M16/0477Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids
    • A61M16/0481Tracheal tubes having openings in the tube with incorporated means for delivering or removing fluids through the cuff wall
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/06Electrodes for high-frequency therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00084Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00106Sensing or detecting at the treatment site ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42Gynaecological or obstetrical instruments or methods
    • A61B2017/4216Operations on uterus, e.g. endometrium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00065Material properties porous
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00059Material properties
    • A61B2018/00071Electrical conductivity
    • A61B2018/00083Electrical conductivity low, i.e. electrically insulating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • A61B2018/0025Multiple balloons
    • A61B2018/00261Multiple balloons arranged in a line
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00559Female reproductive organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00642Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • A61B2018/00654Sensing and controlling the application of energy with feedback, i.e. closed loop control with individual control of each of a plurality of energy emitting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00666Sensing and controlling the application of energy using a threshold value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00666Sensing and controlling the application of energy using a threshold value
    • A61B2018/00678Sensing and controlling the application of energy using a threshold value upper
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • A61B2018/00708Power or energy switching the power on or off
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00761Duration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00827Current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00869Phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00875Resistance or impedance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00886Duration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00892Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00898Alarms or notifications created in response to an abnormal condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/0091Handpieces of the surgical instrument or device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/0091Handpieces of the surgical instrument or device
    • A61B2018/00916Handpieces of the surgical instrument or device with means for switching or controlling the main function of the instrument or device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00982Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B2018/044Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
    • A61B2018/046Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/1206Generators therefor
    • A61B2018/124Generators therefor switching the output to different electrodes, e.g. sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1472Probes or electrodes therefor for use with liquid electrolyte, e.g. virtual electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002Irrigation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1052Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1086Balloon catheters with special features or adapted for special applications having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/02Radiation therapy using microwaves
    • A61N5/04Radiators for near-field treatment

Definitions

  • the present invention relates to a method and apparatus for treating airway obstructions. More specifically, the present invention relates to a method and apparatus for reducing the volume of turbinates in a nasal passageway in order reduce nasal airway obstructions.
  • Sleep-apnea syndrome is a medical condition characterized by daytime hypersomnomulence, morning arm aches, intellectual deterioration, cardiac arrhythmias, snoring and thrashing during sleep. It is caused by frequent episodes of apnea during the patient's sleep.
  • the syndrome is classically subdivided into two types.
  • One type termed "central sleep apnea syndrome”
  • central sleep apnea syndrome is characterized by repeated loss of respiratory effort.
  • the second type termed obstructive sleep apnea syndrome, is characterized by repeated apneic episodes during sleep resulting from obstruction of the patient's upper airway or that portion of the patient's respiratory tract which is cephalad to, and does not include, the larynx.
  • Treatments for sleep apnea thus far include various medical, surgical and physical measures to unobstruct the airways.
  • Medical measures include the use of medications such as protriptyline, medroxyprogesterone, acetazolamide, theophylline, nicotine and other medications in addition to avoidance of central nervous system depressants such as sedatives or alcohol.
  • the above medical measures are sometimes helpful but are rarely completely effective. Further, the medications frequently have undesirable side effects.
  • Surgical interventions have included uvulopalatopharyngoplasty, tonsillectomy, surgery to correct severe retrognathia and tracheostomy.
  • Other surgical procedures include pulling the tongue as forward as possible and surgically cutting and removing sections of the tongue and other structures which can close off the upper airway passage. These procedures may be effective but the risk of surgery in these patients can be prohibitive and the procedures are often unacceptable to the patients.
  • nasal passageways leading from the nose to the pharynx there are three nasal passageways, namely the inferior, middle and superior nasal meatus.
  • the turbinates, also referred to as nasal concha are a series of tissues which form at least a portion of these nasal passageways. Forming a portion of the inferior nasal meatus is the inferior nasal concha.
  • the inferior and middle nasal concha each form a portion of the middle nasal meatus.
  • the middle and superior nasal concha each form a portion of the superior nasal meatus.
  • Opening of obstructed nasal airways by reducing the size of the turbinates has been performed using surgical and pharmaceutical treatments.
  • surgical procedures include anterior and posterior ethmoidectomy, such as those described in "Endoscopic Paranasal Sinus Surgery" by D. Rice and S. Schaefer, Raven Press, 1988); the writings of M. E. Wigand, Messerklinger and Stamberger; and U.S. Pat. No. 5,094,233.
  • the Wigand procedure involves the transection of the middle turbinate, beginning with the posterior aspect, visualization of the sphenoid ostium and opening of the posterior ethmoid cells for subsequent surgery.
  • the ostium of the sphenoid is identified and the anterior wall of the sinus removed.
  • the posterior ethmoid cells may be entered at their junction with the sphenoid and the fovea ethmoidalis can be identified as an anatomical landmark for further dissection.
  • anterior ethmoidectomy the exenteration of the ethmoids is carried anteriorly to the frontal recess. Complications, such as hemorrhage, infection, perforation of the fovea ethmoidalis or lamina papyracea, and scarring or adhesion of the middle turbinate, are reported in connection with these procedures.
  • U.S. Pat. No. 3,901,241 teaches a cryosurgical instrument which is said to be useful for shrinking nasal turbinates.
  • compositions have also been developed for reducing the size of the turbinates.
  • pharmaceuticals are not always completely efficacious and generally do not provide a permanent reduction in turbinate size.
  • pharmaceuticals can have adverse side effects.
  • the present invention relates to a method and apparatus for ablating at least a portion of a nasal concha.
  • the apparatus includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, and an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein.
  • the apparatus in another embodiment, includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, the distal portion including an expandable member, expansion of the expandable member within the nasal meatus immobilizing the distal portion within the nasal meatus, and an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein.
  • the expandable member may be designed to conform to a surface of the nasal concha when expanded and/or to a contour of the nasal meatus.
  • the apparatus may further include a lumen positioned within the catheter for delivering a medium into the expandable member to expand the expandable member and a medium source for delivering the medium through the lumen into the expandable member.
  • the apparatus in another embodiment, includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a surface of a nasal concha, an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein, and an expandable member coupled to the distal portion having a cooling surface, expansion of the expandable member within the nasal meatus placing the cooling surface into contact with a surface of the nasal concha to cool the nasal concha surface.
  • the cooling surface preferably provides sufficient cooling to prevent the ablation of the nasal concha surface.
  • the apparatus may further include a lumen positioned within the catheter for delivering a medium into the expandable member to expand the expandable member adjacent the surface of the nasal concha and a medium source for delivering medium of a sufficiently low temperature to cool the surface of the nasal concha. Expansion of the expandable member may also be used to immobilize the catheter distal end within the nasal meatus.
  • the expandable member may be designed to conform to a surface of the nasal concha when expanded and/or to a contour of the nasal meatus.
  • the one or more energy delivering probes may extend a fixed or variable distance from the catheter distal portion.
  • the one or more energy delivering probes are preferably retractable into the catheter distal portion and extendable from the catheter distal portion. At least two energy delivering probes are preferably included in the energy delivery device.
  • An insulator may be used in combination with the probes to control where energy is delivered. In one variation, the insulator is movable relative to the one or more energy delivering probes.
  • the energy delivering probes are adapted to deliver one of a variety of forms of ablative energy including, for example, RF, microwave, ultrasonic, pulsed laser and diffuse laser energy.
  • the probes are preferably needle electrodes.
  • the probes are preferably optical fibers.
  • the probes preferably include microwave antenna.
  • the probes preferably include ultrasound transducers.
  • the apparatus may further include at least one sensor coupled to the processor.
  • the sensor may be used to measure a variety of properties, including an amount of energy delivered by the energy delivery device, an amount of heat generated at a location, an amount of impedance generated, and a temperature at a location.
  • the energy delivered to the energy delivery device may also be controlled by the processor in response to a measured property.
  • the apparatus may further include an energy source coupled to the energy delivery device for delivering energy to the probes.
  • the distal portion of the catheter is positioned through a nostril of a patient into a nasal meatus adjacent a surface of a nasal concha.
  • the one or more energy delivering probes are then introduced into an interior of the nasal concha.
  • Sufficient ablative energy is then delivered into the interior of the nasal concha to ablate at least a portion of the nasal concha.
  • the nasal concha is preferably the inferior nasal concha and the nasal meatus is preferably the inferior nasal meatus.
  • the portion of the nasal concha ablated is preferably an anterior section of the inferior nasal concha. More preferably, less than one-third of the inferior nasal concha in the anterior portion of the inferior nasal concha is ablated.
  • the nasal concha is preferably reduced in size a sufficient amount to increase the rate of airflow through the nasal meatus at a given pressure by at least 25%.
  • ablation of the nasal concha is preferably done without ablating the surface of the nasal concha.
  • Prevention of the surface tissue of the nasal concha from being ablated can be performed by the step of cooling the surface of the nasal concha during the delivery of energy.
  • the catheter includes an expandable member coupled to the catheter distal portion.
  • the method further includes the step of expanding the expandable member within the nasal meatus to immobilize the distal portion within the nasal meatus. Expansion of the expandable member may be performed by delivering a medium into the expandable member which may be delivered through a lumen within the catheter into the expandable member. This medium may also be used in the method to cool the surface of the nasal concha during the delivery of energy in order to prevent the surface of the nasal concha from being ablating.
  • delivery of ablative energy can be performed substantially bloodlessly.
  • the step of removing the ablated nasal concha tissue is performed substantially bloodlessly and without introducing an element into the nasal concha.
  • FIG. 1 illustrates the construction of the nasal passageways of the human nose.
  • FIG. 2 illustrates the effect enlargement of a nasal concha has on a nasal air passageway.
  • FIGS. 3A-3C illustrate an embodiment of a method for ablating a nasal concha.
  • FIG. 3A illustrates the introduction of an apparatus through a nostril into a nasal meatus adjacent a surface of a nasal concha.
  • FIG. 3B illustrates the extension of an energy delivery device from the apparatus into an interior of the nasal concha and the delivery of energy into the nasal concha.
  • FIG. 3C illustrates the immobilization of the apparatus within the nasal meatus and the cooling of the surface of the nasal concha during the delivery of energy to the nasal concha.
  • FIGS. 4A-C illustrate the steps of ablating a portion of a nasal concha according to the present invention.
  • FIG. 4A illustrates the step of introducing ablative energy into an interior section of a nasal concha.
  • FIG. 4B illustrates an ablated tissue region and its absorption by the body.
  • FIG. 4C illustrates the resulting reduction in the size of the nasal concha.
  • FIG. 5 illustrates an apparatus according to the present invention.
  • FIG. 6 illustrates an apparatus according to the present invention with an expandable member for immobilizing the apparatus within a nasal meatus.
  • FIG. 7 is a block diagram of a feedback control system useful with the method and apparatus of the present invention.
  • FIG. 8 is a block diagram illustrating an analog amplifier, analog multiplexer and microprocessor used with the feedback control system of FIG. 7.
  • FIG. 9 is a block diagram of a temperature/impedance feedback system that can be used to control cooling medium flow rate through an apparatus of the present invention.
  • the present invention provides a method and apparatus for ablating at least a portion of a nasal concha (turbinate). By ablating at least a portion of a nasal concha, the size of the nasal concha can be reduced. Accordingly, the present invention also provides a method for reducing the size of a nasal concha.
  • the three nasal concha in the body form at least a portion of three nasal meatus (inferior, middle and superior nasal meatus).
  • By reducing the size of a nasal concha obstruction of a nasal meatus can be reduced.
  • air flow through the nasal meatus is improved.
  • the present invention also relates to a method for improving airflow through a nasal meatus of the body.
  • FIG. 1 illustrates the construction of the nasal passageways of the human nose 100.
  • the human nose includes a nostril 102 which leads into the nasal passageways from outside the body and a nasopharyngeal opening 104 which leads into the nasal passageways from the pharynx 106.
  • Connecting the nostril 102 and nasopharyngeal opening 104 are a series of passageways, namely the inferior nasal meatus 108, the middle nasal meatus 110, and the superior nasal meatus 112.
  • Forming at least a portion of each of these passageways are the nasal concha, also referred to as the turbinates.
  • Forming at least a portion of the inferior nasal meatus 108 is the inferior nasal concha 114.
  • the inferior nasal concha 114 forms at least a portion of the middle nasal meatus 110 and the inferior nasal concha 116.
  • Forming at least a portion of the superior nasal meatus 112 is the middle nasal concha 116 and the superior nasal concha 118.
  • the inferior nasal concha 114 includes an anterior portion 120 which terminates adjacent the nasopharyngeal opening 104 and a posterior portion 122 which terminates adjacent the nostril 102.
  • Ablation of a nasal concha is accomplished according to the present invention by physically introducing an energy delivery device into an interior section of nasal concha tissue to deliver ablative energy therein.
  • the energy delivery device is designed to be minimally invasive such that the energy delivery device is introduced into the nasal concha without significantly injuring the surface of the nasal concha (aside from where the energy delivery device enters the nasal concha).
  • narrow bore needle-shaped probes for delivering energy may be used in the energy delivery device for insertion into the nasal concha.
  • the use of energy delivered by a minimally invasive means to ablate interior nasal concha tissue eliminates the need for surgical cutting to remove a portion of a nasal concha and the risks associated therewith.
  • the procedure can be performed substantially bloodlessly and without having to expose tissue interior to the nasal concha, thereby significantly reducing the risk of infection.
  • Ablation can also be performed to remove an internal portion of the nasal concha without injuring the surface of the nasal concha (aside from where the energy delivery device enters the nasal concha). For example, by inserting the energy delivery device into the interior of the nasal concha and delivering energy to the nasal concha away from the surface of the nasal concha, interior tissue of the nasal concha can be ablated without simultaneously ablating the surface of the nasal concha. Cooling of the surface of the nasal concha may also be performed to prevent ablation of the surface of the nasal concha.
  • the present invention provides a method and apparatus for reducing the size of a nasal concha without significantly injuring the surface of the nasal concha. By avoiding injury to the surface of the nasal concha, use of the apparatus of the present invention should be significantly less painful to the patient than traditional surgical methods for removing nasal concha tissue.
  • the method includes ablating no more than about one-third of the inferior nasal concha 114.
  • FIG. 2 illustrates the effect enlargement of a nasal concha has on a nasal air passageway.
  • enlargement of the inferior nasal concha 114 can result in an obstruction of inferior nasal meatus 108.
  • region below dashed line 123 By reducing the size of the inferior nasal concha 114, illustrated in FIG. 2 by region below dashed line 123, the inferior nasal meatus 108 is reopened.
  • FIGS. 3A-3C illustrate an embodiment of this method.
  • an apparatus 124 having a distal portion 128 and an energy delivery device 134 for delivering ablative energy is introduced through a nostril 102 of a patient and into a nasal meatus adjacent a surface of a nasal concha, shown in FIGS. 3A-3C as the inferior nasal meatus 108 and the inferior nasal concha 114.
  • the energy delivery device 134 shown in the figures includes three probes 139 for delivering ablative energy. These probes are preferably contained within the distal portion 128 of the apparatus during introduction into the nasal meatus and are extended from the distal portion 128 after introduction.
  • the probes 139 are delivered through the surface 115 of the nasal concha 114 and into an interior section of the nasal concha.
  • the apparatus may be designed such that the probes of the energy delivery device 134 extend a fixed length from the apparatus.
  • the energy delivery device 134 may be designed to be at least partially extendable from the distal portion 128 and/or at least partially retractable into the distal portion 128.
  • ablative energy 117 is delivered through the apparatus and the energy delivery device 134 to an area 119 of the nasal concha 114 adjacent the probes 139. Sufficient energy 117 is delivered during this step to ablate at least a portion of the nasal concha 114.
  • the ablative energy may be any form of energy capable of causing the ablation of tissue by heating at least a portion of the nasal concha being treated to a temperature above about 40° C.
  • types of energy include, but are not limited to energy from a diode laser ablation, a laser fiber (defused), microwave (915 MHz and 2.45 GHz), ultrasound, and RF at all relevant frequencies.
  • the energy is electromagnetic energy and is preferably RF radiation or microwave radiation. Illustrated in FIG. 3B are a series of RF electrodes 139 as the energy delivery device 134.
  • the invention is also intended to encompass the use of probes designed to deliver different forms of energy.
  • the energy used is RF radiation
  • the energy preferably has a frequency between about 300 megahertz and about 700 megahertz.
  • the RF energy delivered to the nasal concha is preferably sufficient to deliver between about 5 and about 30 watts of RF energy to at least a portion of the nasal concha being treated.
  • the apparatus of the present invention may be designed to be immobilized within the nasal meatus. This may be accomplished, for example, by including an expandable member on the apparatus distal portion 128, illustrated in FIG. 3C and FIG. 6 as element 132.
  • the expandable member 132 When expanded within the nasal meatus 108, the expandable member 132 serves to immobilize the apparatus distal portion 128 relative to the nasal concha 114 to be ablated. Accordingly, the method may optionally further include the step of immobilizing the apparatus distal portion relative to the nasal concha. Further, when the apparatus includes an expandable member, the step of immobilizing the apparatus within the nasal meatus may include the step of expanding the expandable member within the nasal meatus.
  • the surface 115 of the nasal concha 114 may also be cooled during the delivery of energy 117. Cooling the surface 115 of the nasal concha 114 may be accomplished, for example, by cooling the distal portion 128 of the apparatus within the nasal meatus.
  • the apparatus may include an expandable member 132 attached to the apparatus at the distal portion 128.
  • the apparatus also includes a lumen 136 coupled to the apparatus for delivering a medium 138 through apertures 137 in the lumen 136 to expand the expandable member 132.
  • the medium is delivered from a media source 159 through the lumen 136 to within the expandable member 132.
  • cool media may be delivered from the media source 159 into the expandable member to cool the surface 115 of the nasal concha.
  • Cooling the surface of the nasal concha being treated with energy serves at least two purposes. Cooling may be used to prevent ablation of the surface 115 of the nasal concha 114 by preventing the surface 115 from reaching a temperature at which the tissue becomes ablated. In this regard, it is preferred that the cooling be sufficient to prevent the surface tissue of the nasal concha from exceeding a temperature of about 40° C.
  • Cooling may also be used to control the location of the ablation site.
  • cooling the nasal concha surface enables the formation of an entirely internal ablation site.
  • the extent of cooling provided, in combination with the positioning of the energy delivery device 134 and the amount of energy delivered, can be used to control the thickness of non-ablated tissue between the surface of the nasal concha and the internal ablation site.
  • the nasal meatus into which the apparatus is delivered may be the inferior, middle and/or superior nasal meatus and is preferably the inferior nasal meatus.
  • the nasal concha ablated may be the inferior, middle and/or superior nasal concha and is preferably the inferior nasal concha.
  • energy is delivered to a selected section of one of the nasal concha.
  • energy may be selectively delivered to the anterior or posterior sections of the inferior nasal concha. Delivery of energy to a selected section of a nasal concha may be accomplished by the placement of the apparatus within the nasal meatus. The delivery of energy to a selected section of a nasal concha may also be accomplished by insulating at least a portion of the nasal concha from ablative energy.
  • an insulative covering 142 may be positioned over a portion of the energy delivery device 134 to control the delivery of energy to a selected section of tissue.
  • the positioning of the insulative covering 142 may be adjustable relative to the energy delivery device 134.
  • the method may optionally include the further step of delivering energy to a portion of a nasal concha while insulating another portion of the nasal concha.
  • the method may also optionally include the step of adjusting the position of the insulating covering 142 relative to the energy delivery device 134.
  • the present invention also relates to a method for reducing the size of a nasal concha.
  • the size of a nasal concha is reduced by ablating tissue forming a nasal concha and removing the ablated nasal concha tissue. Removal of the ablated nasal concha tissue is preferably accomplished by natural absorption of ablated tissue by the patient's body.
  • FIGS. 4A-C illustrate the removal of an internal region of tissue by ablation.
  • FIG. 4A illustrates introducing ablative energy 117 via energy delivery device probes 139 into an interior section 144 of a nasal concha 114. Cooling of the surface 115 of the nasal concha 114 may be performed in order to prevent the ablation of the surface of the nasal concha.
  • FIG. 4B illustrates the absorption (illustrated by arrows 148) of a region 146 of ablated tissue by the body.
  • the ablated tissue region 146 is an interior region, i.e., the surface 115 of the nasal concha is not ablated. This may be achieved by cooling the surface 115 of the nasal concha during the delivery of ablative energy to the nasal concha. It may also be achieved by controlling the positioning of the energy delivery device 134 relative to the surface 115 and by controlling the amount of energy delivered by the energy delivery device 134.
  • FIG. 4C illustrates the resulting reduction in the size of the nasal concha after absorption.
  • Region 149 illustrates the volume of tissue that is removed from the path of the nasal meatus by this method. As can be seen by comparing FIGS. 4A and 4C, the size of nasal meatus 108 is enlarged by this process.
  • the present invention also relates to a method for improving airflow through a nasal meatus by reducing the size of a nasal concha which defines at least a portion of the nasal meatus.
  • This method can be accomplished by the method for reducing the size of a nasal concha as described above.
  • the rate of airflow through the nasal meatus at a given pressure is increased by at least 25%.
  • the present invention also relates to an apparatus for ablating a nasal concha.
  • the apparatus 124 includes a catheter 126 which has a distal portion 128 with dimensions configured for introduction through a nostril of a patient into a nasal meatus of a patient.
  • the apparatus also includes an energy delivery device 134.
  • the energy delivery device 134 is illustrated in the figure as including a plurality of probes 139 designed to pierce the nasal concha and deliver ablative energy therein.
  • each probe preferably includes a pointed distal end 135.
  • the probes 139 of the energy delivery device 134 may extend a fixed distance from the catheter distal portion 128. In such case, the probes 139 should extend from the catheter distal portion 128 a sufficient distance necessary to ablate an interior portion of the nasal concha 114.
  • the energy delivery device 134 may be designed to be at least partially extendable from the catheter distal portion 128 and/or at least partially retractable into the catheter distal portion 128.
  • the energy delivery device 134 should also be configured to selectively introduce the probes into the nasal concha or a selected subregion of the nasal concha. Accordingly, when a plurality of probes 139 are used as illustrated in FIG. 5, the probes should be positioned relative to the catheter distal portion 128 so that the probes 139 are all introduced into the nasal concha and not into other tissue adjacent the nasal concha.
  • the probes 139 used in the energy delivery device 134 may be any probe which can pierce the surface of a nasal concha and which can deliver a form of energy capable of causing the ablation of tissue.
  • Ablation is preferably performed by heating at least a portion of the nasal concha to be treated to a temperature above about 40° C.
  • types of energy include, but are not limited to energy from a diode laser ablation, a laser fiber (defused), microwave (915 MHz and 2.45 GHz), ultrasound, and RF at all relevant frequencies.
  • the energy is electromagnetic energy and is preferably RF radiation or microwave radiation delivered into the nasal concha by one or more needle electrodes.
  • the energy when the energy is RF radiation, the energy preferably has a frequency between about 300 megahertz and about 700 megahertz.
  • the RF energy delivered to the nasal concha is preferably sufficient to deliver between about 5 and about 30 watts of RF energy to at least a portion of the nasal concha being treated.
  • the energy delivery device may optionally include an insulator 162 surrounding each probe 139 which prevents the delivery of ablative energy 117 through at least a portion of the probe 139.
  • the insulator 162 may be moved relative to the energy delivery device 134 to cause energy to be delivered to a selected section of a nasal concha while preventing the ablation of another selected section of tissue.
  • an expandable member 132 may be attached to the catheter 126 at the catheter distal portion 128.
  • the expandable member can be used to immobilize the catheter distal portion 128 within the nasal meatus by expanding against the walls forming the nasal meatus.
  • the expandable member preferably conforms to a contour of the nasal meatus when expanded. In one embodiment, the expandable member conforms to the surface of the nasal concha when expanded.
  • FIG. 6 A variety of mechanisms are known in the art which may be used to expand the expandable member 132.
  • One mechanism, illustrated in FIG. 6, involves the use of a lumen 136 coupled with the catheter 126 for delivering a medium 138 to expand the expandable member 132.
  • the medium is delivered from a media source 159 through the lumen 136 to within the expandable member 132 through apertures 137.
  • the apertures 137 may be formed by a sheath 150 which substantially surrounds the lumen 136.
  • the sheath 150 is formed of a relatively inert and relatively hard substance, such as metallic copper or metallic silver.
  • the sheath 150 includes some other inert substance, such as gold, stainless steel, titanium, various plastic compounds, or some combination thereof.
  • the expandable member illustrated in FIG. 6 can also be used to cool the surface of a nasal concha being ablated. Cooling may be accomplished by introducing cool medium into the expandable member. This may be accomplished, for example, by including a cooling mechanism into the media source 159 to cool the media.
  • ablative energy is supplied to the energy delivery device by an energy source 162.
  • an energy source 162 As discussed above, a variety of forms of ablative energy may be used in the present invention. Accordingly, the energy source is selected to provide the desired form of energy.
  • the energy source 162 includes an energy source 163 (or a power regulator coupled to a standard energy source such as a wall socket or battery), a signal generator 165 (such as a generator for pulses, sine waves, square waves, or some combination of these wave forms with each other or with some other wave form), and a processor 167 for controlling the signal generator.
  • an energy source 163 or a power regulator coupled to a standard energy source such as a wall socket or battery
  • a signal generator 165 such as a generator for pulses, sine waves, square waves, or some combination of these wave forms with each other or with some other wave form
  • a processor 167 for controlling the signal generator.
  • the signal generator generates pulses of RF energy having an RF radiation frequency between about 300 megahertz and about 700 megahertz, such as preferably about 465 megahertz.
  • the RF energy may have an RF radiation frequency in the microwave range or in another range of the electromagnetic spectrum.
  • the processor controls the amount of energy delivered by the apparatus.
  • the apparatus can further include a signal generator coupled to the energy delivery device and coupled to a energy source.
  • the apparatus can also include a processor coupled to the signal generator and disposed for controlling the signal generator.
  • the processor can control the way in which energy is delivered.
  • the signal generator can generate pulses of RF energy which provide between about 5 watts and about 30 watts of RF energy to at least a portion of the turbinate.
  • the processor can also control the amount of energy produced so that the region of turbinate tissue to be ablated is heated to a temperature of at least 40° C.
  • the apparatus can also include one or more sensors. These sensors can be used to detect a variety of operating parameters including the amount of energy delivered, the impedance generated, and the temperature of a region adjacent the apparatus. These sensors can also be used to provide feedback for controlling the operation of an energy source which delivers energy to the energy delivery device. In addition, chemical or biochemical sensors can be used to detect ablation.
  • the apparatus includes at least one temperature sensor, such as a thermocouple or thermistor.
  • the temperature sensor is coupled to a communication link (such as a conductor), which is coupled to the processor.
  • the communication link may comprise a D/A converter coupled to a register disposed for reading by the processor.
  • the processor reads an sensor value from the sensor and, responsive thereto, controls the signal generator so as to achieve delivery of an effective amount of RF energy to a desired section of tissue to be ablated.
  • the processor thus uses the signal generator, catheter distal portion, energy delivery device, and temperature sensor, as a feedback loop for controlled delivery of RF energy to a section of a nasal concha.
  • the processor may control the delivery of RF energy to achieve delivery of a selected amount of energy, to achieve a selected temperature, or to achieve a selected amount of ablation of a section of a nasal concha.
  • the sensor is coupled to the expandable member.
  • the temperature or some other property of the tissue being ablated, or of the energy delivery device can be monitored using a variety of sensors. Illustrated in FIGS. 7 and 8 is an open and a closed loop feedback system for coupling a sensor used in the apparatus to an energy source so that the output energy of the energy source is adjusted in relation to the property sensed by the sensor.
  • the feedback system is described herein with regard to the delivery of RF energy. It should be noted, however, that the feedback system can be readily adjusted for use with a variety of other types of energy, such as microwaves.
  • the physician can, if desired, override the closed or open loop system.
  • a microprocessor can be included and incorporated in the closed or open loop system to switch energy on and off, as well as modulate the energy.
  • the closed loop system utilizes a microprocessor to serve as a controller, watch the temperature, adjust the amount of energy being delivered, look at the result, re-feed the result, and then modulate the energy.
  • the sensors and feedback control system can be used to, maintained tissue adjacent to an energy delivery device at a desired temperature for a selected period of time without impeding out.
  • An output maintains the energy delivered to the energy delivery device for a selected length of time.
  • a control signal is generated by controller 198 that is proportional to the difference between an actual measured value, and a desired value.
  • the control signal is used by energy circuits 200 to adjust the energy output in an appropriate amount in order to maintain the desired energy delivered at each energy delivery device 189.
  • temperatures detected at temperature sensors 191 provide feedback for maintaining a selected energy.
  • the actual temperatures are measured at temperature measurement device 202, and the temperatures are displayed at user interface and display 196.
  • a control signal is generated by controller 198 that is proportional to the difference between an actual measured temperature, and a desired temperature.
  • the control signal is used by energy circuits 200 to adjust the energy output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensor.
  • a multiplexer can be included to measure current, voltage and temperature, at numerous sensors, and energy can be delivered to the energy delivery device 189 in monopolar or bipolar fashion.
  • Controller 198 can be a digital or analog controller, or a computer with software.
  • controller 198 is a computer it can include a CPU coupled through a system bus.
  • On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art.
  • Also coupled to the bus is a program memory and a data memory.
  • User interface and display 196 includes operator controls and a display.
  • Controller 198 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.
  • the output of current sensor 190 and voltage sensor 192 is used by controller 198 to maintain a selected energy level at energy delivery device 189.
  • the amount of energy delivered controls the amount of energy.
  • a profile of energy delivered can be incorporated in controller 198, and a preset amount of energy to be delivered can also be profiled.
  • Circuitry, software and feedback to controller 198 result in process control, and the maintenance of the selected energy that is independent of changes in voltage or current, and are used to change, (i) the selected energy, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery, and (iv) infusion medium delivery, including flow rate and pressure.
  • process variables are controlled and varied, while maintaining the desired delivery of energy independent of changes in voltage or current, based on temperatures monitored at sensors 191.
  • Analog amplifier 204 can be a conventional differential amplifier circuit for use with temperature sensors 191.
  • the output of analog amplifier 204 is sequentially connected by an analog multiplexer 206 to the input of AND converter 208.
  • the output of analog amplifier 204 is a voltage which represents the respective sensed temperatures.
  • Digitized amplifier output voltages are supplied by A/D converter 208 to microprocessor 188.
  • Microprocessor 188 may be a type 68HCII available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature.
  • Microprocessor 188 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 188 corresponds to different temperatures and impedances.
  • Calculated energy and impedance values can be indicated on user interface and display 196.
  • calculated impedance and energy values can be compared by microprocessor 188 with energy and impedance limits. When the values exceed predetermined energy or impedance values, a warning can be given on user interface and display 196, and additionally, the delivery of RF energy can be reduced, modified or interrupted.
  • a control signal from microprocessor 188 can modify the energy level supplied by energy source 203
  • FIG. 9 illustrates a block diagram of a temperature/impedance feedback system that can be used to control cooling medium flow rate through the catheter into the expandable member.
  • Ablative energy is delivered to energy delivery device 189 by energy source 203, and applied to tissue.
  • a monitor 210 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value a disabling signal 211 is transmitted to energy source 203, ceasing further delivery of energy to the energy delivery device 189. If measured impedance is within acceptable limits, energy continues to be applied to the tissue.
  • tissue sensor 191 measures the temperature of tissue and/or energy delivery device 189.
  • a comparator 214 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. Comparator 214 sends a signal to a flow regulator 216 representing a need for a higher cooling medium flow rate, if the tissue temperature is too high, or to maintain the flow rate if the temperature has not exceeded the desired temperature.

Abstract

A method and apparatus for ablating at least a portion of a nasal concha. The apparatus includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, and an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein. The distal portion of the apparatus may also include an expandable member, expansion of the expandable member within the nasal meatus immobilizing the distal portion within the nasal meatus.

Description

RELATIONSHIP TO COPENDING APPLICATIONS
This application is a continuation-in-part of application Ser. No. 08/754,588, "Method for Ablating Turbinates", filed Oct. 19, 1996; application Ser. No. 08/753,063, "Apparatus for Ablating Turbinates", filed Oct. 19, 1996 and application Ser. No. 08/752,076, "Noninvasive Apparatus for Ablating Turbinates", filed Oct. 19, 1996 all of which are continuation-in-part applications of application Ser. No. 08/651,796, "Method and Apparatus for Ablating Turbinates" filed May 22, 1996 and of application Ser. No. 08/651,798, "Method and Apparatus for Ablating Turbinates", filed May 22, 1996; all of which are a continuation-in-part of application Ser. No. 08/265,459, now U.S. Pat. No. 5,505,730. "Thin Layer Ablation Apparatus", filed Jun. 24, 1994, all of which are incorporated herein by reference.
FIELD OF THE INVENTION
The present invention relates to a method and apparatus for treating airway obstructions. More specifically, the present invention relates to a method and apparatus for reducing the volume of turbinates in a nasal passageway in order reduce nasal airway obstructions.
BACKGROUND OF THE INVENTION
Sleep-apnea syndrome is a medical condition characterized by daytime hypersomnomulence, morning arm aches, intellectual deterioration, cardiac arrhythmias, snoring and thrashing during sleep. It is caused by frequent episodes of apnea during the patient's sleep. The syndrome is classically subdivided into two types. One type, termed "central sleep apnea syndrome", is characterized by repeated loss of respiratory effort. The second type, termed obstructive sleep apnea syndrome, is characterized by repeated apneic episodes during sleep resulting from obstruction of the patient's upper airway or that portion of the patient's respiratory tract which is cephalad to, and does not include, the larynx.
Treatments for sleep apnea thus far include various medical, surgical and physical measures to unobstruct the airways. Medical measures include the use of medications such as protriptyline, medroxyprogesterone, acetazolamide, theophylline, nicotine and other medications in addition to avoidance of central nervous system depressants such as sedatives or alcohol. The above medical measures are sometimes helpful but are rarely completely effective. Further, the medications frequently have undesirable side effects.
Surgical interventions have included uvulopalatopharyngoplasty, tonsillectomy, surgery to correct severe retrognathia and tracheostomy. Other surgical procedures include pulling the tongue as forward as possible and surgically cutting and removing sections of the tongue and other structures which can close off the upper airway passage. These procedures may be effective but the risk of surgery in these patients can be prohibitive and the procedures are often unacceptable to the patients.
Among the air passageways in the body that can become obstructed are the nasal passageways leading from the nose to the pharynx. There are three nasal passageways, namely the inferior, middle and superior nasal meatus. The turbinates, also referred to as nasal concha, are a series of tissues which form at least a portion of these nasal passageways. Forming a portion of the inferior nasal meatus is the inferior nasal concha. The inferior and middle nasal concha each form a portion of the middle nasal meatus. The middle and superior nasal concha each form a portion of the superior nasal meatus. When the inferior, middle and/or superior nasal concha become enlarged, the various nasal meatus which allow air to pass through the nose into the pharynx can become obstructed.
Opening of obstructed nasal airways by reducing the size of the turbinates has been performed using surgical and pharmaceutical treatments. Examples of surgical procedures include anterior and posterior ethmoidectomy, such as those described in "Endoscopic Paranasal Sinus Surgery" by D. Rice and S. Schaefer, Raven Press, 1988); the writings of M. E. Wigand, Messerklinger and Stamberger; and U.S. Pat. No. 5,094,233. For example, as described in U.S. Pat. No. 5,094,233, the Wigand procedure involves the transection of the middle turbinate, beginning with the posterior aspect, visualization of the sphenoid ostium and opening of the posterior ethmoid cells for subsequent surgery. In the sphenoidectomy step, the ostium of the sphenoid is identified and the anterior wall of the sinus removed. Following this step, the posterior ethmoid cells may be entered at their junction with the sphenoid and the fovea ethmoidalis can be identified as an anatomical landmark for further dissection. In anterior ethmoidectomy, the exenteration of the ethmoids is carried anteriorly to the frontal recess. Complications, such as hemorrhage, infection, perforation of the fovea ethmoidalis or lamina papyracea, and scarring or adhesion of the middle turbinate, are reported in connection with these procedures.
One of the problems encountered as a result of these procedures is postoperative adhesion occurring between the turbinates and adjacent nasal areas, such as medial adhesion to the septum and lateral adhesion to the lateral nasal wall in the area of the ethmoid sinuses. Otherwise successful surgical procedures may have poor results in these cases. Some surgeons have proposed amputation of a portion of the turbinate at the conclusion of surgery to avoid this complication, resulting in protracted morbidity (crust formation and nasal hygiene problems). The turbinate adhesion problem detracts from these endoscopic surgical procedures. Efforts have been made to reduce the complications associated with the surgical treatment of turbinate tissue, for example by the use of a turbinate sheath device. U.S. Pat. No. 5,094,233.
U.S. Pat. No. 3,901,241 teaches a cryosurgical instrument which is said to be useful for shrinking nasal turbinates. U.S. Pat. No. 3,901,241.
Pharmaceuticals have also been developed for reducing the size of the turbinates. However, pharmaceuticals are not always completely efficacious and generally do not provide a permanent reduction in turbinate size. In addition, pharmaceuticals can have adverse side effects.
A need exists for a method and device for clearing obstructed nasal passageways. It is preferred that the method and device be performable with minimal surgical intervention or post operative complications. It is also preferred that the method and device be performable to reduce the size of the turbinates without involving surgical cutting or the physical removal of tissue. It is also preferred that the method and device provide a permanent reduction in turbinate size.
SUMMARY OF THE INVENTION
The present invention relates to a method and apparatus for ablating at least a portion of a nasal concha. In one embodiment, the apparatus includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, and an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein.
In another embodiment, the apparatus includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, the distal portion including an expandable member, expansion of the expandable member within the nasal meatus immobilizing the distal portion within the nasal meatus, and an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein.
In this embodiment, the expandable member may be designed to conform to a surface of the nasal concha when expanded and/or to a contour of the nasal meatus. In this embodiment, the apparatus may further include a lumen positioned within the catheter for delivering a medium into the expandable member to expand the expandable member and a medium source for delivering the medium through the lumen into the expandable member.
In another embodiment, the apparatus includes a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a surface of a nasal concha, an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein, and an expandable member coupled to the distal portion having a cooling surface, expansion of the expandable member within the nasal meatus placing the cooling surface into contact with a surface of the nasal concha to cool the nasal concha surface.
In this embodiment, the cooling surface preferably provides sufficient cooling to prevent the ablation of the nasal concha surface. The apparatus may further include a lumen positioned within the catheter for delivering a medium into the expandable member to expand the expandable member adjacent the surface of the nasal concha and a medium source for delivering medium of a sufficiently low temperature to cool the surface of the nasal concha. Expansion of the expandable member may also be used to immobilize the catheter distal end within the nasal meatus. In this embodiment, the expandable member may be designed to conform to a surface of the nasal concha when expanded and/or to a contour of the nasal meatus.
In any of the above embodiments, the one or more energy delivering probes may extend a fixed or variable distance from the catheter distal portion. The one or more energy delivering probes are preferably retractable into the catheter distal portion and extendable from the catheter distal portion. At least two energy delivering probes are preferably included in the energy delivery device. An insulator may be used in combination with the probes to control where energy is delivered. In one variation, the insulator is movable relative to the one or more energy delivering probes.
In any of the above embodiments, the energy delivering probes are adapted to deliver one of a variety of forms of ablative energy including, for example, RF, microwave, ultrasonic, pulsed laser and diffuse laser energy. When delivering RF energy, the probes are preferably needle electrodes. When delivering laser energy, the probes are preferably optical fibers. When delivering microwave energy, the probes preferably include microwave antenna. When delivering ultrasonic energy, the probes preferably include ultrasound transducers.
In any of the above embodiments, the apparatus may further include at least one sensor coupled to the processor. The sensor may be used to measure a variety of properties, including an amount of energy delivered by the energy delivery device, an amount of heat generated at a location, an amount of impedance generated, and a temperature at a location. The energy delivered to the energy delivery device may also be controlled by the processor in response to a measured property.
In any of the above embodiments, the apparatus may further include an energy source coupled to the energy delivery device for delivering energy to the probes.
A method is also provided for ablating at least a portion of a nasal concha using a catheter having a distal portion with a dimension configured for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha and an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes. In the method, the distal portion of the catheter is positioned through a nostril of a patient into a nasal meatus adjacent a surface of a nasal concha. The one or more energy delivering probes are then introduced into an interior of the nasal concha. Sufficient ablative energy is then delivered into the interior of the nasal concha to ablate at least a portion of the nasal concha. In the method, the nasal concha is preferably the inferior nasal concha and the nasal meatus is preferably the inferior nasal meatus. The portion of the nasal concha ablated is preferably an anterior section of the inferior nasal concha. More preferably, less than one-third of the inferior nasal concha in the anterior portion of the inferior nasal concha is ablated. The nasal concha is preferably reduced in size a sufficient amount to increase the rate of airflow through the nasal meatus at a given pressure by at least 25%.
According to the method, ablation of the nasal concha is preferably done without ablating the surface of the nasal concha. Prevention of the surface tissue of the nasal concha from being ablated can be performed by the step of cooling the surface of the nasal concha during the delivery of energy.
In one variation of this method, the catheter includes an expandable member coupled to the catheter distal portion. According to this variation, the method further includes the step of expanding the expandable member within the nasal meatus to immobilize the distal portion within the nasal meatus. Expansion of the expandable member may be performed by delivering a medium into the expandable member which may be delivered through a lumen within the catheter into the expandable member. This medium may also be used in the method to cool the surface of the nasal concha during the delivery of energy in order to prevent the surface of the nasal concha from being ablating.
By using the energy delivering probes, delivery of ablative energy can be performed substantially bloodlessly. In addition, by allowing the ablated tissue to be removed by natural absorption, the step of removing the ablated nasal concha tissue is performed substantially bloodlessly and without introducing an element into the nasal concha.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 illustrates the construction of the nasal passageways of the human nose.
FIG. 2 illustrates the effect enlargement of a nasal concha has on a nasal air passageway.
FIGS. 3A-3C illustrate an embodiment of a method for ablating a nasal concha.
FIG. 3A illustrates the introduction of an apparatus through a nostril into a nasal meatus adjacent a surface of a nasal concha.
FIG. 3B illustrates the extension of an energy delivery device from the apparatus into an interior of the nasal concha and the delivery of energy into the nasal concha.
FIG. 3C illustrates the immobilization of the apparatus within the nasal meatus and the cooling of the surface of the nasal concha during the delivery of energy to the nasal concha.
FIGS. 4A-C illustrate the steps of ablating a portion of a nasal concha according to the present invention.
FIG. 4A illustrates the step of introducing ablative energy into an interior section of a nasal concha.
FIG. 4B illustrates an ablated tissue region and its absorption by the body.
FIG. 4C illustrates the resulting reduction in the size of the nasal concha.
FIG. 5 illustrates an apparatus according to the present invention.
FIG. 6 illustrates an apparatus according to the present invention with an expandable member for immobilizing the apparatus within a nasal meatus.
FIG. 7 is a block diagram of a feedback control system useful with the method and apparatus of the present invention.
FIG. 8 is a block diagram illustrating an analog amplifier, analog multiplexer and microprocessor used with the feedback control system of FIG. 7.
FIG. 9 is a block diagram of a temperature/impedance feedback system that can be used to control cooling medium flow rate through an apparatus of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The present invention provides a method and apparatus for ablating at least a portion of a nasal concha (turbinate). By ablating at least a portion of a nasal concha, the size of the nasal concha can be reduced. Accordingly, the present invention also provides a method for reducing the size of a nasal concha. The three nasal concha in the body (inferior, middle and superior nasal concha) form at least a portion of three nasal meatus (inferior, middle and superior nasal meatus). By reducing the size of a nasal concha, obstruction of a nasal meatus can be reduced. By reducing an obstruction of a nasal meatus, air flow through the nasal meatus is improved. Accordingly, the present invention also relates to a method for improving airflow through a nasal meatus of the body.
FIG. 1 illustrates the construction of the nasal passageways of the human nose 100. As illustrated in the figure, the human nose includes a nostril 102 which leads into the nasal passageways from outside the body and a nasopharyngeal opening 104 which leads into the nasal passageways from the pharynx 106. Connecting the nostril 102 and nasopharyngeal opening 104 are a series of passageways, namely the inferior nasal meatus 108, the middle nasal meatus 110, and the superior nasal meatus 112. Forming at least a portion of each of these passageways are the nasal concha, also referred to as the turbinates. Forming at least a portion of the inferior nasal meatus 108 is the inferior nasal concha 114. Forming at least a portion of the middle nasal meatus 110 is the inferior nasal concha 114 and the middle nasal concha 116. Forming at least a portion of the superior nasal meatus 112 is the middle nasal concha 116 and the superior nasal concha 118. As also shown in FIG. 1, the inferior nasal concha 114 includes an anterior portion 120 which terminates adjacent the nasopharyngeal opening 104 and a posterior portion 122 which terminates adjacent the nostril 102.
Ablation of a nasal concha is accomplished according to the present invention by physically introducing an energy delivery device into an interior section of nasal concha tissue to deliver ablative energy therein. In the method and apparatus, the energy delivery device is designed to be minimally invasive such that the energy delivery device is introduced into the nasal concha without significantly injuring the surface of the nasal concha (aside from where the energy delivery device enters the nasal concha). For example, narrow bore needle-shaped probes for delivering energy may be used in the energy delivery device for insertion into the nasal concha.
The use of energy delivered by a minimally invasive means to ablate interior nasal concha tissue eliminates the need for surgical cutting to remove a portion of a nasal concha and the risks associated therewith. In particular, the procedure can be performed substantially bloodlessly and without having to expose tissue interior to the nasal concha, thereby significantly reducing the risk of infection.
Ablation can also be performed to remove an internal portion of the nasal concha without injuring the surface of the nasal concha (aside from where the energy delivery device enters the nasal concha). For example, by inserting the energy delivery device into the interior of the nasal concha and delivering energy to the nasal concha away from the surface of the nasal concha, interior tissue of the nasal concha can be ablated without simultaneously ablating the surface of the nasal concha. Cooling of the surface of the nasal concha may also be performed to prevent ablation of the surface of the nasal concha. As a result, the present invention provides a method and apparatus for reducing the size of a nasal concha without significantly injuring the surface of the nasal concha. By avoiding injury to the surface of the nasal concha, use of the apparatus of the present invention should be significantly less painful to the patient than traditional surgical methods for removing nasal concha tissue.
According to the present invention, it is preferred to ablate the inferior nasal concha 114, and more preferably an anterior portion 120 of the inferior nasal concha 114. In a preferred embodiment, the anterior portion 120 of the inferior nasal concha 114 is defined as being no larger than about one-third the volume of the inferior nasal concha 114. Thus, in one embodiment, the method includes ablating no more than about one-third of the inferior nasal concha 114.
FIG. 2 illustrates the effect enlargement of a nasal concha has on a nasal air passageway. As shown in FIG. 2, enlargement of the inferior nasal concha 114 can result in an obstruction of inferior nasal meatus 108. By reducing the size of the inferior nasal concha 114, illustrated in FIG. 2 by region below dashed line 123, the inferior nasal meatus 108 is reopened.
I. Method For Turbinate Ablation
One aspect of the present invention relates to a method for ablating nasal concha tissue. FIGS. 3A-3C illustrate an embodiment of this method. As shown in FIG. 3A, an apparatus 124 having a distal portion 128 and an energy delivery device 134 for delivering ablative energy is introduced through a nostril 102 of a patient and into a nasal meatus adjacent a surface of a nasal concha, shown in FIGS. 3A-3C as the inferior nasal meatus 108 and the inferior nasal concha 114.
The energy delivery device 134 shown in the figures includes three probes 139 for delivering ablative energy. These probes are preferably contained within the distal portion 128 of the apparatus during introduction into the nasal meatus and are extended from the distal portion 128 after introduction.
As illustrated in FIG. 3B, the probes 139 are delivered through the surface 115 of the nasal concha 114 and into an interior section of the nasal concha. The apparatus may be designed such that the probes of the energy delivery device 134 extend a fixed length from the apparatus. Alternatively, as illustrated in FIG. 3B by arrow (⃡), the energy delivery device 134 may be designed to be at least partially extendable from the distal portion 128 and/or at least partially retractable into the distal portion 128.
Once the probes 139 of the energy delivery device 134 are positioned within the nasal concha, ablative energy 117 is delivered through the apparatus and the energy delivery device 134 to an area 119 of the nasal concha 114 adjacent the probes 139. Sufficient energy 117 is delivered during this step to ablate at least a portion of the nasal concha 114.
According to this method, the ablative energy may be any form of energy capable of causing the ablation of tissue by heating at least a portion of the nasal concha being treated to a temperature above about 40° C. Examples of types of energy that may be used include, but are not limited to energy from a diode laser ablation, a laser fiber (defused), microwave (915 MHz and 2.45 GHz), ultrasound, and RF at all relevant frequencies. In a preferred embodiment, the energy is electromagnetic energy and is preferably RF radiation or microwave radiation. Illustrated in FIG. 3B are a series of RF electrodes 139 as the energy delivery device 134. The invention is also intended to encompass the use of probes designed to deliver different forms of energy.
When the energy used is RF radiation, the energy preferably has a frequency between about 300 megahertz and about 700 megahertz. The RF energy delivered to the nasal concha is preferably sufficient to deliver between about 5 and about 30 watts of RF energy to at least a portion of the nasal concha being treated.
The apparatus of the present invention may be designed to be immobilized within the nasal meatus. This may be accomplished, for example, by including an expandable member on the apparatus distal portion 128, illustrated in FIG. 3C and FIG. 6 as element 132.
When expanded within the nasal meatus 108, the expandable member 132 serves to immobilize the apparatus distal portion 128 relative to the nasal concha 114 to be ablated. Accordingly, the method may optionally further include the step of immobilizing the apparatus distal portion relative to the nasal concha. Further, when the apparatus includes an expandable member, the step of immobilizing the apparatus within the nasal meatus may include the step of expanding the expandable member within the nasal meatus.
The surface 115 of the nasal concha 114 may also be cooled during the delivery of energy 117. Cooling the surface 115 of the nasal concha 114 may be accomplished, for example, by cooling the distal portion 128 of the apparatus within the nasal meatus. As illustrated in FIG. 3C, the apparatus may include an expandable member 132 attached to the apparatus at the distal portion 128. In this embodiment, the apparatus also includes a lumen 136 coupled to the apparatus for delivering a medium 138 through apertures 137 in the lumen 136 to expand the expandable member 132. The medium is delivered from a media source 159 through the lumen 136 to within the expandable member 132. During ablation, cool media may be delivered from the media source 159 into the expandable member to cool the surface 115 of the nasal concha.
Cooling the surface of the nasal concha being treated with energy serves at least two purposes. Cooling may be used to prevent ablation of the surface 115 of the nasal concha 114 by preventing the surface 115 from reaching a temperature at which the tissue becomes ablated. In this regard, it is preferred that the cooling be sufficient to prevent the surface tissue of the nasal concha from exceeding a temperature of about 40° C.
Cooling may also be used to control the location of the ablation site. For example, cooling the nasal concha surface enables the formation of an entirely internal ablation site. The extent of cooling provided, in combination with the positioning of the energy delivery device 134 and the amount of energy delivered, can be used to control the thickness of non-ablated tissue between the surface of the nasal concha and the internal ablation site.
According to the method, the nasal meatus into which the apparatus is delivered may be the inferior, middle and/or superior nasal meatus and is preferably the inferior nasal meatus. The nasal concha ablated may be the inferior, middle and/or superior nasal concha and is preferably the inferior nasal concha. In one embodiment, energy is delivered to a selected section of one of the nasal concha. For example, energy may be selectively delivered to the anterior or posterior sections of the inferior nasal concha. Delivery of energy to a selected section of a nasal concha may be accomplished by the placement of the apparatus within the nasal meatus. The delivery of energy to a selected section of a nasal concha may also be accomplished by insulating at least a portion of the nasal concha from ablative energy.
As also illustrated in FIG. 3C, an insulative covering 142 may be positioned over a portion of the energy delivery device 134 to control the delivery of energy to a selected section of tissue. The positioning of the insulative covering 142 may be adjustable relative to the energy delivery device 134. Accordingly, the method may optionally include the further step of delivering energy to a portion of a nasal concha while insulating another portion of the nasal concha. The method may also optionally include the step of adjusting the position of the insulating covering 142 relative to the energy delivery device 134.
The present invention also relates to a method for reducing the size of a nasal concha. According to the method, the size of a nasal concha is reduced by ablating tissue forming a nasal concha and removing the ablated nasal concha tissue. Removal of the ablated nasal concha tissue is preferably accomplished by natural absorption of ablated tissue by the patient's body.
FIGS. 4A-C illustrate the removal of an internal region of tissue by ablation. FIG. 4A illustrates introducing ablative energy 117 via energy delivery device probes 139 into an interior section 144 of a nasal concha 114. Cooling of the surface 115 of the nasal concha 114 may be performed in order to prevent the ablation of the surface of the nasal concha.
FIG. 4B illustrates the absorption (illustrated by arrows 148) of a region 146 of ablated tissue by the body. As illustrated in FIG. 4B, the ablated tissue region 146 is an interior region, i.e., the surface 115 of the nasal concha is not ablated. This may be achieved by cooling the surface 115 of the nasal concha during the delivery of ablative energy to the nasal concha. It may also be achieved by controlling the positioning of the energy delivery device 134 relative to the surface 115 and by controlling the amount of energy delivered by the energy delivery device 134.
FIG. 4C illustrates the resulting reduction in the size of the nasal concha after absorption. Region 149 illustrates the volume of tissue that is removed from the path of the nasal meatus by this method. As can be seen by comparing FIGS. 4A and 4C, the size of nasal meatus 108 is enlarged by this process.
The present invention also relates to a method for improving airflow through a nasal meatus by reducing the size of a nasal concha which defines at least a portion of the nasal meatus. This method can be accomplished by the method for reducing the size of a nasal concha as described above. In one embodiment, the rate of airflow through the nasal meatus at a given pressure is increased by at least 25%.
2. Turbinate Ablation Apparatus
The present invention also relates to an apparatus for ablating a nasal concha. As illustrated in FIG. 5, the apparatus 124 includes a catheter 126 which has a distal portion 128 with dimensions configured for introduction through a nostril of a patient into a nasal meatus of a patient.
The apparatus also includes an energy delivery device 134. The energy delivery device 134 is illustrated in the figure as including a plurality of probes 139 designed to pierce the nasal concha and deliver ablative energy therein. In order to facilitate the entry of the probes into the nasal concha, each probe preferably includes a pointed distal end 135.
The probes 139 of the energy delivery device 134 may extend a fixed distance from the catheter distal portion 128. In such case, the probes 139 should extend from the catheter distal portion 128 a sufficient distance necessary to ablate an interior portion of the nasal concha 114. Alternatively, as illustrated in FIG. 5 by the arrow (⃡), the energy delivery device 134 may be designed to be at least partially extendable from the catheter distal portion 128 and/or at least partially retractable into the catheter distal portion 128.
The energy delivery device 134 should also be configured to selectively introduce the probes into the nasal concha or a selected subregion of the nasal concha. Accordingly, when a plurality of probes 139 are used as illustrated in FIG. 5, the probes should be positioned relative to the catheter distal portion 128 so that the probes 139 are all introduced into the nasal concha and not into other tissue adjacent the nasal concha.
The probes 139 used in the energy delivery device 134 may be any probe which can pierce the surface of a nasal concha and which can deliver a form of energy capable of causing the ablation of tissue. Ablation is preferably performed by heating at least a portion of the nasal concha to be treated to a temperature above about 40° C. Examples of types of energy that may be used include, but are not limited to energy from a diode laser ablation, a laser fiber (defused), microwave (915 MHz and 2.45 GHz), ultrasound, and RF at all relevant frequencies. In a preferred embodiment, the energy is electromagnetic energy and is preferably RF radiation or microwave radiation delivered into the nasal concha by one or more needle electrodes.
When the energy is RF radiation, the energy preferably has a frequency between about 300 megahertz and about 700 megahertz. The RF energy delivered to the nasal concha is preferably sufficient to deliver between about 5 and about 30 watts of RF energy to at least a portion of the nasal concha being treated.
As illustrated in FIG. 5, the energy delivery device may optionally include an insulator 162 surrounding each probe 139 which prevents the delivery of ablative energy 117 through at least a portion of the probe 139. As illustrated in FIG. 5, by the dashed lines 161, the insulator 162 may be moved relative to the energy delivery device 134 to cause energy to be delivered to a selected section of a nasal concha while preventing the ablation of another selected section of tissue.
As illustrated in FIG. 6, an expandable member 132 may be attached to the catheter 126 at the catheter distal portion 128. The expandable member can be used to immobilize the catheter distal portion 128 within the nasal meatus by expanding against the walls forming the nasal meatus. The expandable member preferably conforms to a contour of the nasal meatus when expanded. In one embodiment, the expandable member conforms to the surface of the nasal concha when expanded.
A variety of mechanisms are known in the art which may be used to expand the expandable member 132. One mechanism, illustrated in FIG. 6, involves the use of a lumen 136 coupled with the catheter 126 for delivering a medium 138 to expand the expandable member 132. The medium is delivered from a media source 159 through the lumen 136 to within the expandable member 132 through apertures 137. The apertures 137 may be formed by a sheath 150 which substantially surrounds the lumen 136. In one embodiment, the sheath 150 is formed of a relatively inert and relatively hard substance, such as metallic copper or metallic silver. In alternative embodiments, the sheath 150 includes some other inert substance, such as gold, stainless steel, titanium, various plastic compounds, or some combination thereof.
The expandable member illustrated in FIG. 6 can also be used to cool the surface of a nasal concha being ablated. Cooling may be accomplished by introducing cool medium into the expandable member. This may be accomplished, for example, by including a cooling mechanism into the media source 159 to cool the media.
As illustrated in FIG. 5, ablative energy is supplied to the energy delivery device by an energy source 162. As discussed above, a variety of forms of ablative energy may be used in the present invention. Accordingly, the energy source is selected to provide the desired form of energy.
In one embodiment, the energy source 162 includes an energy source 163 (or a power regulator coupled to a standard energy source such as a wall socket or battery), a signal generator 165 (such as a generator for pulses, sine waves, square waves, or some combination of these wave forms with each other or with some other wave form), and a processor 167 for controlling the signal generator.
In a preferred embodiment, the signal generator generates pulses of RF energy having an RF radiation frequency between about 300 megahertz and about 700 megahertz, such as preferably about 465 megahertz. In alternative embodiments, the RF energy may have an RF radiation frequency in the microwave range or in another range of the electromagnetic spectrum.
The processor controls the amount of energy delivered by the apparatus. In this embodiment, the apparatus can further include a signal generator coupled to the energy delivery device and coupled to a energy source. The apparatus can also include a processor coupled to the signal generator and disposed for controlling the signal generator. According to this embodiment, the processor can control the way in which energy is delivered. For example, the signal generator can generate pulses of RF energy which provide between about 5 watts and about 30 watts of RF energy to at least a portion of the turbinate. The processor can also control the amount of energy produced so that the region of turbinate tissue to be ablated is heated to a temperature of at least 40° C.
In order to monitor the amount of energy delivered and the amount of heat generated, the apparatus can also include one or more sensors. These sensors can be used to detect a variety of operating parameters including the amount of energy delivered, the impedance generated, and the temperature of a region adjacent the apparatus. These sensors can also be used to provide feedback for controlling the operation of an energy source which delivers energy to the energy delivery device. In addition, chemical or biochemical sensors can be used to detect ablation.
In one embodiment, the apparatus includes at least one temperature sensor, such as a thermocouple or thermistor. The temperature sensor is coupled to a communication link (such as a conductor), which is coupled to the processor. For example, in the case where the temperature sensor is a thermocouple, the communication link may comprise a D/A converter coupled to a register disposed for reading by the processor. The processor reads an sensor value from the sensor and, responsive thereto, controls the signal generator so as to achieve delivery of an effective amount of RF energy to a desired section of tissue to be ablated. The processor thus uses the signal generator, catheter distal portion, energy delivery device, and temperature sensor, as a feedback loop for controlled delivery of RF energy to a section of a nasal concha. For example, the processor may control the delivery of RF energy to achieve delivery of a selected amount of energy, to achieve a selected temperature, or to achieve a selected amount of ablation of a section of a nasal concha. A variety of positionings for the sensors are possible. In one embodiment, the sensor is coupled to the expandable member.
As described above, the temperature or some other property of the tissue being ablated, or of the energy delivery device can be monitored using a variety of sensors. Illustrated in FIGS. 7 and 8 is an open and a closed loop feedback system for coupling a sensor used in the apparatus to an energy source so that the output energy of the energy source is adjusted in relation to the property sensed by the sensor. The feedback system, is described herein with regard to the delivery of RF energy. It should be noted, however, that the feedback system can be readily adjusted for use with a variety of other types of energy, such as microwaves.
Using the feedback system, the physician can, if desired, override the closed or open loop system. A microprocessor can be included and incorporated in the closed or open loop system to switch energy on and off, as well as modulate the energy. The closed loop system utilizes a microprocessor to serve as a controller, watch the temperature, adjust the amount of energy being delivered, look at the result, re-feed the result, and then modulate the energy.
In the case of RF energy, the sensors and feedback control system can be used to, maintained tissue adjacent to an energy delivery device at a desired temperature for a selected period of time without impeding out. An output maintains the energy delivered to the energy delivery device for a selected length of time.
As illustrated in FIG. 7, current is delivered through energy delivery device 189 is measured by current sensor 190. Voltage is measured by voltage sensor 192. Impedance and energy are then calculated at energy and impedance calculation device 194. These values can then be displayed at a user interface and display 196. Signals representative of energy and impedance values are received by a controller 198.
A control signal is generated by controller 198 that is proportional to the difference between an actual measured value, and a desired value. The control signal is used by energy circuits 200 to adjust the energy output in an appropriate amount in order to maintain the desired energy delivered at each energy delivery device 189.
In a similar manner, temperatures detected at temperature sensors 191 provide feedback for maintaining a selected energy. The actual temperatures are measured at temperature measurement device 202, and the temperatures are displayed at user interface and display 196. A control signal is generated by controller 198 that is proportional to the difference between an actual measured temperature, and a desired temperature. The control signal is used by energy circuits 200 to adjust the energy output in an appropriate amount in order to maintain the desired temperature delivered at the respective sensor. A multiplexer can be included to measure current, voltage and temperature, at numerous sensors, and energy can be delivered to the energy delivery device 189 in monopolar or bipolar fashion.
Controller 198 can be a digital or analog controller, or a computer with software. When controller 198 is a computer it can include a CPU coupled through a system bus. On this system can be a keyboard, a disk drive, or other non-volatile memory systems, a display, and other peripherals, as are known in the art. Also coupled to the bus is a program memory and a data memory.
User interface and display 196 includes operator controls and a display. Controller 198 can be coupled to imaging systems, including but not limited to ultrasound, CT scanners, X-ray, MRI, mammographic X-ray and the like. Further, direct visualization and tactile imaging can be utilized.
The output of current sensor 190 and voltage sensor 192 is used by controller 198 to maintain a selected energy level at energy delivery device 189. The amount of energy delivered controls the amount of energy. A profile of energy delivered can be incorporated in controller 198, and a preset amount of energy to be delivered can also be profiled.
Circuitry, software and feedback to controller 198 result in process control, and the maintenance of the selected energy that is independent of changes in voltage or current, and are used to change, (i) the selected energy, (ii) the duty cycle (on-off and wattage), (iii) bipolar or monopolar energy delivery, and (iv) infusion medium delivery, including flow rate and pressure. These process variables are controlled and varied, while maintaining the desired delivery of energy independent of changes in voltage or current, based on temperatures monitored at sensors 191.
Current sensor 190 and voltage sensor 192 are connected to the input of an analog amplifier 204. Analog amplifier 204 can be a conventional differential amplifier circuit for use with temperature sensors 191. The output of analog amplifier 204 is sequentially connected by an analog multiplexer 206 to the input of AND converter 208. The output of analog amplifier 204 is a voltage which represents the respective sensed temperatures. Digitized amplifier output voltages are supplied by A/D converter 208 to microprocessor 188. Microprocessor 188 may be a type 68HCII available from Motorola. However, it will be appreciated that any suitable microprocessor or general purpose digital or analog computer can be used to calculate impedance or temperature.
Microprocessor 188 sequentially receives and stores digital representations of impedance and temperature. Each digital value received by microprocessor 188 corresponds to different temperatures and impedances.
Calculated energy and impedance values can be indicated on user interface and display 196. Alternatively, or in addition to the numerical indication of energy or impedance, calculated impedance and energy values can be compared by microprocessor 188 with energy and impedance limits. When the values exceed predetermined energy or impedance values, a warning can be given on user interface and display 196, and additionally, the delivery of RF energy can be reduced, modified or interrupted. A control signal from microprocessor 188 can modify the energy level supplied by energy source 203
FIG. 9 illustrates a block diagram of a temperature/impedance feedback system that can be used to control cooling medium flow rate through the catheter into the expandable member. Ablative energy is delivered to energy delivery device 189 by energy source 203, and applied to tissue. A monitor 210 ascertains tissue impedance, based on the energy delivered to tissue, and compares the measured impedance value to a set value. If the measured impedance exceeds the set value a disabling signal 211 is transmitted to energy source 203, ceasing further delivery of energy to the energy delivery device 189. If measured impedance is within acceptable limits, energy continues to be applied to the tissue. During the application of energy to tissue sensor 191 measures the temperature of tissue and/or energy delivery device 189. A comparator 214 receives a signal representative of the measured temperature and compares this value to a pre-set signal representative of the desired temperature. Comparator 214 sends a signal to a flow regulator 216 representing a need for a higher cooling medium flow rate, if the tissue temperature is too high, or to maintain the flow rate if the temperature has not exceeded the desired temperature.
While the present invention is disclosed by reference to the preferred embodiments and examples detailed above, it is to be understood that these examples are intended in an illustrative rather than limiting sense, as it is contemplated that modifications will readily occur to those skilled in the art, which modifications will be within the spirit of the invention and the scope of the appended claims.

Claims (26)

What is claimed is:
1. An apparatus for ablating at least a portion of a nasal concha comprising:
a catheter having a distal portion with a length operable for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, the catheter further including a catheter longitudinal axis and a catheter side wall; and
an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein, wherein the one or more energy delivering probes are extendable from the catheter side wall in a lateral direction relative to the catheter longitudinal axis.
2. The apparatus according to claim 1 wherein the one or more energy delivering probes extend a fixed distance from the catheter distal portion.
3. The apparatus according to claim 1 wherein the distance the one or more energy delivering probes extend from the catheter distal portion can be varied.
4. The apparatus according to claim 1 wherein the one or more energy delivering probes are retractable into the catheter distal portion and extendable from the catheter distal portion.
5. The apparatus according to claim 1 wherein the energy delivery device includes at least two energy delivering probes.
6. The apparatus according to claim 1 wherein the one or more energy delivering probes deliver energy selected from the group consisting of RF, microwave, ultrasonic, pulsed laser and diffuse laser energy.
7. The apparatus according to claim 1 wherein the one or more energy delivering probes are needle electrodes for delivering RF energy.
8. The apparatus according to claim 1 wherein the one or more energy delivering probes include an optical fiber for delivering laser energy.
9. The apparatus according to claim 1 wherein the one or more energy delivering probes are antenna for delivering microwave energy.
10. The apparatus according to claim 1 wherein the one or more energy delivering probes include transducers for delivering ultrasonic energy.
11. The apparatus according to claim 1 wherein the apparatus further includes an insulator positioned adjacent at least a portion of the one or more energy delivering probes to prevent the delivery of energy therethrough.
12. The apparatus according to claim 11 wherein the insulator is movable relative to the one or more energy delivering probes.
13. The apparatus according to claim 1 wherein the apparatus includes a signal generator coupleable to an energy source for generating pulses of electromagnetic energy having a frequency between about 300 and 700 megahertz.
14. The apparatus according to claim 13, wherein the apparatus further includes a processor coupled to the signal generator for generating pulses of RF energy which provide between about 5 and about 30 watts of RF energy.
15. The apparatus according to claim 14, wherein the apparatus further includes at least one sensor coupled to the processor.
16. The apparatus according to claim 15, wherein the sensor measures a property selected from the group consisting of an amount of energy delivered by the energy delivery device, an amount of heat generated at a location, an amount of impedance generated, and a temperature at a location.
17. The apparatus according to claim 14, wherein the energy delivered to the energy delivery device is controlled by the processor in response to a measured property selected from the group consisting of an amount of energy delivered by the energy delivery device, an amount of heat generated at a location, an amount of impedance generated, and a temperature at a location.
18. The apparatus according to claim 17, wherein the apparatus includes a sensor for measuring the measured property.
19. An apparatus for ablating at least a portion of a nasal concha comprising:
a catheter having a distal portion with a length operable for positioning through a nostril of a patient into a nasal meatus adjacent a nasal concha, the catheter further including a catheter longitudinal axis and a catheter side wall;
an energy delivery device coupled to the catheter distal portion including one or more energy delivering probes extendable from the catheter distal portion a sufficient distance to be inserted into an interior of the nasal concha to deliver ablative energy therein, wherein the one or more energy delivering probes are extendable from the catheter side wall in a lateral direction relative to the catheter longitudinal axis; and
an energy source coupled to the energy delivery device for delivering energy to the probes.
20. The apparatus according to claim 19 wherein the energy source delivers energy to the one or more energy delivering probes selected from the group consisting of RF, microwave, ultrasonic, pulsed laser and diffuses laser energy.
21. The apparatus according to claim 20 wherein the one or more energy delivering probes are needle electrodes for delivering RF energy.
22. The apparatus according to claim 20 wherein the one or more energy delivering probes include an optical fiber for delivering laser energy.
23. The apparatus according to claim 20 wherein the one or more energy delivering probes are antenna for delivering microwave energy.
24. The apparatus according to claim 20 wherein the one or more energy delivering probes include transducers for delivering ultrasonic energy.
25. The apparatus according to claim 20 wherein the apparatus includes a signal generator coupled to the energy source for generating pulses of electromagnetic energy having a frequency between about 300 and 700 megahertz.
26. The apparatus according to claim 25, wherein the apparatus further includes a processor coupled to the signal generator for generating pulses of RF energy which provide between about 5 and about 30 watts of RF energy.
US08/790,081 1994-06-24 1997-01-29 Minimally invasive apparatus for internal ablation of turbinates Expired - Fee Related US5827277A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US08/790,173 US5843077A (en) 1994-06-24 1997-01-29 Minimally invasive apparatus for internal ablation of turbinates with surface cooling
US08/790,081 US5827277A (en) 1994-06-24 1997-01-29 Minimally invasive apparatus for internal ablation of turbinates
AU32040/97A AU3204097A (en) 1996-05-22 1997-05-06 Method and apparatus for ablating turbinates
PCT/US1997/007818 WO1997043971A2 (en) 1996-05-22 1997-05-06 Method and apparatus for ablating turbinates

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US08/265,459 US5505730A (en) 1994-06-24 1994-06-24 Thin layer ablation apparatus
US65179896A 1996-05-22 1996-05-22
US65179696A 1996-05-22 1996-05-22
US75306396A 1996-11-19 1996-11-19
US08/752,076 US5800429A (en) 1994-06-24 1996-11-19 Noninvasive apparatus for ablating turbinates
US08/754,588 US5746224A (en) 1994-06-24 1996-11-19 Method for ablating turbinates
US08/790,081 US5827277A (en) 1994-06-24 1997-01-29 Minimally invasive apparatus for internal ablation of turbinates

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US08/754,588 Continuation-In-Part US5746224A (en) 1994-06-24 1996-11-19 Method for ablating turbinates
US08/752,076 Continuation-In-Part US5800429A (en) 1994-06-24 1996-11-19 Noninvasive apparatus for ablating turbinates
US75306396A Continuation-In-Part 1994-06-24 1996-11-19

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US08/790,173 Continuation-In-Part US5843077A (en) 1994-06-24 1997-01-29 Minimally invasive apparatus for internal ablation of turbinates with surface cooling

Publications (1)

Publication Number Publication Date
US5827277A true US5827277A (en) 1998-10-27

Family

ID=46252484

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/790,081 Expired - Fee Related US5827277A (en) 1994-06-24 1997-01-29 Minimally invasive apparatus for internal ablation of turbinates

Country Status (1)

Country Link
US (1) US5827277A (en)

Cited By (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5974343A (en) * 1996-01-12 1999-10-26 Bruker Sa Probe, particulary a urethral probe, for heating of tissues by microwave and for the measurement of temperature by radiometry
US6053172A (en) 1995-06-07 2000-04-25 Arthrocare Corporation Systems and methods for electrosurgical sinus surgery
US6063079A (en) 1995-06-07 2000-05-16 Arthrocare Corporation Methods for electrosurgical treatment of turbinates
US6086585A (en) 1995-06-07 2000-07-11 Arthrocare Corporation System and methods for electrosurgical treatment of sleep obstructive disorders
US6109268A (en) 1995-06-07 2000-08-29 Arthrocare Corporation Systems and methods for electrosurgical endoscopic sinus surgery
US6159208A (en) 1995-06-07 2000-12-12 Arthocare Corporation System and methods for electrosurgical treatment of obstructive sleep disorders
US6200333B1 (en) 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US6203542B1 (en) 1995-06-07 2001-03-20 Arthrocare Corporation Method for electrosurgical treatment of submucosal tissue
US6273907B1 (en) 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
US6283988B1 (en) 1997-04-07 2001-09-04 Broncus Technologies, Inc. Bronchial stenter having expandable electrodes
US6283989B1 (en) 1997-04-07 2001-09-04 Broncus Technolgies, Inc. Method of treating a bronchial tube with a bronchial stenter having diametrically adjustable electrodes
US6361531B1 (en) 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
US6363937B1 (en) 1995-06-07 2002-04-02 Arthrocare Corporation System and methods for electrosurgical treatment of the digestive system
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6411852B1 (en) 1997-04-07 2002-06-25 Broncus Technologies, Inc. Modification of airways by application of energy
US6413254B1 (en) 2000-01-19 2002-07-02 Medtronic Xomed, Inc. Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6488673B1 (en) 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US20060122587A1 (en) * 2004-11-17 2006-06-08 Shiva Sharareh Apparatus for real time evaluation of tissue ablation
US20060229515A1 (en) * 2004-11-17 2006-10-12 The Regents Of The University Of California Fiber optic evaluation of tissue modification
US20070244529A1 (en) * 2006-04-18 2007-10-18 Zoom Therapeutics, Inc. Apparatus and methods for treatment of nasal tissue
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
US20080027423A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Systems for treatment of nasal tissue
US20090124958A1 (en) * 2007-09-28 2009-05-14 Li Kasey K Device and methods for treatment of tissue
US7740017B2 (en) 1997-04-07 2010-06-22 Asthmatx, Inc. Method for treating an asthma attack
US7837679B2 (en) 2000-10-17 2010-11-23 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US7853331B2 (en) 2004-11-05 2010-12-14 Asthmatx, Inc. Medical device with procedure improvement features
US7892230B2 (en) 2004-06-24 2011-02-22 Arthrocare Corporation Electrosurgical device having planar vertical electrode and related methods
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US7931647B2 (en) 2006-10-20 2011-04-26 Asthmatx, Inc. Method of delivering energy to a lung airway using markers
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US8235983B2 (en) 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US8257413B2 (en) 2000-10-17 2012-09-04 Asthmatx, Inc. Modification of airways by application of energy
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8747401B2 (en) 2011-01-20 2014-06-10 Arthrocare Corporation Systems and methods for turbinate reduction
US8808280B2 (en) 2008-05-09 2014-08-19 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US8920413B2 (en) 2004-11-12 2014-12-30 Asthmatx, Inc. Energy delivery devices and methods
US8936594B2 (en) 2011-06-14 2015-01-20 Aerin Medical Inc. Methods and devices to treat nasal airways
US8986301B2 (en) 2012-06-13 2015-03-24 Aerin Medical Inc. Methods and devices to treat nasal airways
US9011428B2 (en) 2011-03-02 2015-04-21 Arthrocare Corporation Electrosurgical device with internal digestor electrode
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9168082B2 (en) 2011-02-09 2015-10-27 Arthrocare Corporation Fine dissection electrosurgical device
US9204921B2 (en) 2012-12-13 2015-12-08 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9254166B2 (en) 2013-01-17 2016-02-09 Arthrocare Corporation Systems and methods for turbinate reduction
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9271784B2 (en) 2011-02-09 2016-03-01 Arthrocare Corporation Fine dissection electrosurgical device
US9283374B2 (en) 2012-11-05 2016-03-15 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US9364277B2 (en) 2012-12-13 2016-06-14 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9408662B2 (en) 2012-05-07 2016-08-09 Cook Medical Technologies Llc Sphincterotome having expandable tines
US9415194B2 (en) 2011-06-14 2016-08-16 Aerin Medical Inc. Post nasal drip treatment
US9510905B2 (en) 2014-11-19 2016-12-06 Advanced Cardiac Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
US9517103B2 (en) 2014-11-19 2016-12-13 Advanced Cardiac Therapeutics, Inc. Medical instruments with multiple temperature sensors
US9592086B2 (en) 2012-07-24 2017-03-14 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9636164B2 (en) 2015-03-25 2017-05-02 Advanced Cardiac Therapeutics, Inc. Contact sensing systems and methods
US9770293B2 (en) 2012-06-04 2017-09-26 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
US9788882B2 (en) 2011-09-08 2017-10-17 Arthrocare Corporation Plasma bipolar forceps
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
US9993178B2 (en) 2016-03-15 2018-06-12 Epix Therapeutics, Inc. Methods of determining catheter orientation
US20180271612A1 (en) * 2014-07-25 2018-09-27 Arrinex, Inc. Apparatus and Method for Treating Rhinitis
US10166062B2 (en) 2014-11-19 2019-01-01 Epix Therapeutics, Inc. High-resolution mapping of tissue with pacing
US10307200B2 (en) 2013-09-30 2019-06-04 Arrinex, Inc. Apparatus and methods for treating rhinitis
US10335280B2 (en) 2000-01-19 2019-07-02 Medtronic, Inc. Method for ablating target tissue of a patient
US10413188B2 (en) 2004-11-17 2019-09-17 Lawrence Livermore National Security, Llc Assessment of tissue or lesion depth using temporally resolved light scattering spectroscopy
US10448992B2 (en) 2010-10-22 2019-10-22 Arthrocare Corporation Electrosurgical system with device specific operational parameters
US10456185B2 (en) 2011-06-14 2019-10-29 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10478247B2 (en) 2013-08-09 2019-11-19 Boston Scientific Scimed, Inc. Expandable catheter and related methods of manufacture and use
US20190374666A1 (en) * 2018-06-07 2019-12-12 Dickey Arndt Systems and method for decontaminating a tube
US10603059B2 (en) 2013-09-13 2020-03-31 Aerin Medical Inc. Hyaline cartilage shaping
USD880694S1 (en) 2017-05-01 2020-04-07 Aerin Medical, Inc. Nasal airway medical instrument
USD881904S1 (en) 2018-10-31 2020-04-21 Aerin Medical Inc. Display screen with animated graphical user interface
US20200179681A1 (en) * 2018-12-11 2020-06-11 Neurent Medical Limited Systems and methods for therapeutic nasal neuromodulation
US10722282B2 (en) 2011-06-14 2020-07-28 Aerin Medical, Inc. Methods and devices to treat nasal airways
USD902412S1 (en) 2018-10-31 2020-11-17 Aerin Medical, Inc. Electrosurgery console
US10864035B2 (en) 2016-03-04 2020-12-15 Aerin Medical, Inc. Eustachian tube modification
US10888373B2 (en) 2017-04-27 2021-01-12 Epix Therapeutics, Inc. Contact assessment between an ablation catheter and tissue
US11033318B2 (en) 2011-06-14 2021-06-15 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11096738B2 (en) 2017-05-05 2021-08-24 Aerin Medical, Inc. Treatment of spinal tissue
US11116566B2 (en) 2016-12-22 2021-09-14 Aerin Medical, Inc. Soft palate treatment
US11241271B2 (en) 2011-06-14 2022-02-08 Aerin Medical Inc. Methods of treating nasal airways
US11278356B2 (en) 2017-04-28 2022-03-22 Arrinex, Inc. Systems and methods for locating blood vessels in the treatment of rhinitis
US11304746B2 (en) 2011-06-14 2022-04-19 Aerin Medical Inc. Method of treating airway tissue to reduce mucus secretion
US11771497B2 (en) 2015-05-12 2023-10-03 National University Of Ireland, Galway Devices for therapeutic nasal neuromodulation and associated methods and systems
US11806071B2 (en) 2016-12-22 2023-11-07 Aerin Medical Inc. Soft palate treatment
EP4069119A4 (en) * 2019-12-07 2023-12-13 APYX Medical Corporation Devices, systems and methods for calculating the amount of energy delivered to tissue during an electrosurgical treatment
US11883091B2 (en) 2020-04-09 2024-01-30 Neurent Medical Limited Systems and methods for improving sleep with therapeutic nasal treatment
US11896818B2 (en) 2020-04-09 2024-02-13 Neurent Medical Limited Systems and methods for therapeutic nasal treatment

Citations (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933157A (en) * 1973-10-23 1976-01-20 Aktiebolaget Stille-Werner Test and control device for electrosurgical apparatus
US3990452A (en) * 1975-06-13 1976-11-09 Fibra-Sonics, Inc. Medical machine for performing surgery and treating using ultrasonic energy
US4011872A (en) * 1974-04-01 1977-03-15 Olympus Optical Co., Ltd. Electrical apparatus for treating affected part in a coeloma
US4411266A (en) * 1980-09-24 1983-10-25 Cosman Eric R Thermocouple radio frequency lesion electrode
US4476862A (en) * 1980-12-08 1984-10-16 Pao David S C Method of scleral marking
US4532924A (en) * 1980-05-13 1985-08-06 American Hospital Supply Corporation Multipolar electrosurgical device and method
US4565200A (en) * 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4674499A (en) * 1980-12-08 1987-06-23 Pao David S C Coaxial bipolar probe
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4947842A (en) * 1988-09-22 1990-08-14 Medical Engineering And Development Institute, Inc. Method and apparatus for treating tissue with first and second modalities
US4966597A (en) * 1988-11-04 1990-10-30 Cosman Eric R Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection
US4976711A (en) * 1989-04-13 1990-12-11 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5057107A (en) * 1989-04-13 1991-10-15 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5078717A (en) * 1989-04-13 1992-01-07 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5083565A (en) * 1990-08-03 1992-01-28 Everest Medical Corporation Electrosurgical instrument for ablating endocardial tissue
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5122137A (en) * 1990-04-27 1992-06-16 Boston Scientific Corporation Temperature controlled rf coagulation
WO1992010142A1 (en) * 1990-12-10 1992-06-25 Howmedica Inc. A device and method for interstitial laser energy delivery
US5125928A (en) * 1989-04-13 1992-06-30 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5190541A (en) * 1990-10-17 1993-03-02 Boston Scientific Corporation Surgical instrument and method
US5197963A (en) * 1991-12-02 1993-03-30 Everest Medical Corporation Electrosurgical instrument with extendable sheath for irrigation and aspiration
US5197964A (en) * 1991-11-12 1993-03-30 Everest Medical Corporation Bipolar instrument utilizing one stationary electrode and one movable electrode
US5215103A (en) * 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5257451A (en) * 1991-11-08 1993-11-02 Ep Technologies, Inc. Method of making durable sleeve for enclosing a bendable electrode tip assembly
US5275162A (en) * 1991-11-08 1994-01-04 Ep Technologies, Inc. Valve mapping catheter
US5281217A (en) * 1992-04-13 1994-01-25 Ep Technologies, Inc. Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5293869A (en) * 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5309910A (en) * 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5313943A (en) * 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5314466A (en) * 1992-04-13 1994-05-24 Ep Technologies, Inc. Articulated unidirectional microwave antenna systems for cardiac ablation
US5328467A (en) * 1991-11-08 1994-07-12 Ep Technologies, Inc. Catheter having a torque transmitting sleeve
US5348554A (en) * 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5363861A (en) * 1991-11-08 1994-11-15 Ep Technologies, Inc. Electrode tip assembly with variable resistance to bending
US5366490A (en) * 1992-08-12 1994-11-22 Vidamed, Inc. Medical probe device and method
US5365926A (en) * 1986-11-14 1994-11-22 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5368592A (en) * 1992-04-13 1994-11-29 Ep Technologies, Inc. Articulated systems for cardiac ablation
US5370678A (en) * 1992-04-13 1994-12-06 Ep Technologies, Inc. Steerable microwave antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5383876A (en) * 1992-11-13 1995-01-24 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical probe for cutting and cauterizing tissue
US5383917A (en) * 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5385544A (en) * 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5397339A (en) * 1986-11-14 1995-03-14 Desai; Jawahar M. Catheter for mapping and ablation and method therefor
US5398683A (en) * 1991-05-24 1995-03-21 Ep Technologies, Inc. Combination monophasic action potential/ablation catheter and high-performance filter system
US5403311A (en) * 1993-03-29 1995-04-04 Boston Scientific Corporation Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5409453A (en) * 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
US5421819A (en) * 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5423808A (en) * 1991-11-08 1995-06-13 Ep Technologies, Inc. Systems and methods for radiofrequency ablation with phase sensitive power detection
US5433739A (en) * 1993-11-02 1995-07-18 Sluijter; Menno E. Method and apparatus for heating an intervertebral disc for relief of back pain
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5456682A (en) * 1991-11-08 1995-10-10 Ep Technologies, Inc. Electrode and associated systems using thermally insulated temperature sensing elements
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5458597A (en) * 1993-11-08 1995-10-17 Zomed International Device for treating cancer and non-malignant tumors and methods
US5458596A (en) * 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5470308A (en) * 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5471982A (en) * 1992-09-29 1995-12-05 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5472441A (en) * 1993-11-08 1995-12-05 Zomed International Device for treating cancer and non-malignant tumors and methods
US5484400A (en) * 1992-08-12 1996-01-16 Vidamed, Inc. Dual channel RF delivery system
US5486161A (en) * 1993-02-02 1996-01-23 Zomed International Medical probe device and method
US5500012A (en) * 1992-07-15 1996-03-19 Angeion Corporation Ablation catheter system
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5507743A (en) * 1993-11-08 1996-04-16 Zomed International Coiled RF electrode treatment apparatus
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5514130A (en) * 1994-10-11 1996-05-07 Dorsal Med International RF apparatus for controlled depth ablation of soft tissue
US5520684A (en) * 1993-06-10 1996-05-28 Imran; Mir A. Transurethral radio frequency apparatus for ablation of the prostate gland and method
US5536267A (en) * 1993-11-08 1996-07-16 Zomed International Multiple electrode ablation apparatus
US5542916A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Dual-channel RF power delivery system
US5542915A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US5545161A (en) * 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US5545171A (en) * 1994-09-22 1996-08-13 Vidamed, Inc. Anastomosis catheter
US5545193A (en) * 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5549644A (en) * 1992-08-12 1996-08-27 Vidamed, Inc. Transurethral needle ablation device with cystoscope and method for treatment of the prostate
US5549108A (en) * 1992-09-25 1996-08-27 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5556377A (en) * 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5558673A (en) * 1994-09-30 1996-09-24 Vidamed, Inc. Medical probe device and method having a flexible resilient tape stylet
WO1996029946A1 (en) * 1995-03-24 1996-10-03 Board Of Regents Of The University Of Nebraska Apparatus for ablation of tissue masses
US5571154A (en) * 1993-07-19 1996-11-05 Hunan University Microwave deep-diathermy apparatus
US5672173A (en) * 1995-08-15 1997-09-30 Rita Medical Systems, Inc. Multiple antenna ablation apparatus and method

Patent Citations (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933157A (en) * 1973-10-23 1976-01-20 Aktiebolaget Stille-Werner Test and control device for electrosurgical apparatus
US4011872A (en) * 1974-04-01 1977-03-15 Olympus Optical Co., Ltd. Electrical apparatus for treating affected part in a coeloma
US3990452A (en) * 1975-06-13 1976-11-09 Fibra-Sonics, Inc. Medical machine for performing surgery and treating using ultrasonic energy
US4532924A (en) * 1980-05-13 1985-08-06 American Hospital Supply Corporation Multipolar electrosurgical device and method
US4565200A (en) * 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4411266A (en) * 1980-09-24 1983-10-25 Cosman Eric R Thermocouple radio frequency lesion electrode
US4674499A (en) * 1980-12-08 1987-06-23 Pao David S C Coaxial bipolar probe
US4476862A (en) * 1980-12-08 1984-10-16 Pao David S C Method of scleral marking
US5365926A (en) * 1986-11-14 1994-11-22 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5215103A (en) * 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
US5397339A (en) * 1986-11-14 1995-03-14 Desai; Jawahar M. Catheter for mapping and ablation and method therefor
US4907589A (en) * 1988-04-29 1990-03-13 Cosman Eric R Automatic over-temperature control apparatus for a therapeutic heating device
US4947842A (en) * 1988-09-22 1990-08-14 Medical Engineering And Development Institute, Inc. Method and apparatus for treating tissue with first and second modalities
US4966597A (en) * 1988-11-04 1990-10-30 Cosman Eric R Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection
US5078717A (en) * 1989-04-13 1992-01-07 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5125928A (en) * 1989-04-13 1992-06-30 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5057107A (en) * 1989-04-13 1991-10-15 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US4976711A (en) * 1989-04-13 1990-12-11 Everest Medical Corporation Ablation catheter with selectively deployable electrodes
US5122137A (en) * 1990-04-27 1992-06-16 Boston Scientific Corporation Temperature controlled rf coagulation
US5083565A (en) * 1990-08-03 1992-01-28 Everest Medical Corporation Electrosurgical instrument for ablating endocardial tissue
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5190541A (en) * 1990-10-17 1993-03-02 Boston Scientific Corporation Surgical instrument and method
WO1992010142A1 (en) * 1990-12-10 1992-06-25 Howmedica Inc. A device and method for interstitial laser energy delivery
US5398683A (en) * 1991-05-24 1995-03-21 Ep Technologies, Inc. Combination monophasic action potential/ablation catheter and high-performance filter system
US5383917A (en) * 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5456682A (en) * 1991-11-08 1995-10-10 Ep Technologies, Inc. Electrode and associated systems using thermally insulated temperature sensing elements
US5257451A (en) * 1991-11-08 1993-11-02 Ep Technologies, Inc. Method of making durable sleeve for enclosing a bendable electrode tip assembly
US5275162A (en) * 1991-11-08 1994-01-04 Ep Technologies, Inc. Valve mapping catheter
US5423808A (en) * 1991-11-08 1995-06-13 Ep Technologies, Inc. Systems and methods for radiofrequency ablation with phase sensitive power detection
US5328467A (en) * 1991-11-08 1994-07-12 Ep Technologies, Inc. Catheter having a torque transmitting sleeve
US5363861A (en) * 1991-11-08 1994-11-15 Ep Technologies, Inc. Electrode tip assembly with variable resistance to bending
US5197964A (en) * 1991-11-12 1993-03-30 Everest Medical Corporation Bipolar instrument utilizing one stationary electrode and one movable electrode
US5290286A (en) * 1991-11-12 1994-03-01 Everest Medical Corporation Bipolar instrument utilizing one stationary electrode and one movable electrode
US5197963A (en) * 1991-12-02 1993-03-30 Everest Medical Corporation Electrosurgical instrument with extendable sheath for irrigation and aspiration
US5314466A (en) * 1992-04-13 1994-05-24 Ep Technologies, Inc. Articulated unidirectional microwave antenna systems for cardiac ablation
US5281217A (en) * 1992-04-13 1994-01-25 Ep Technologies, Inc. Steerable antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5368592A (en) * 1992-04-13 1994-11-29 Ep Technologies, Inc. Articulated systems for cardiac ablation
US5370678A (en) * 1992-04-13 1994-12-06 Ep Technologies, Inc. Steerable microwave antenna systems for cardiac ablation that minimize tissue damage and blood coagulation due to conductive heating patterns
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5500012A (en) * 1992-07-15 1996-03-19 Angeion Corporation Ablation catheter system
US5540655A (en) * 1992-08-12 1996-07-30 Vidamed, Inc. PBH ablation method and apparatus
US5542915A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Thermal mapping catheter with ultrasound probe
US5385544A (en) * 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US5556377A (en) * 1992-08-12 1996-09-17 Vidamed, Inc. Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe
US5370675A (en) * 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US5554110A (en) * 1992-08-12 1996-09-10 Vidamed, Inc. Medical ablation apparatus
US5409453A (en) * 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
US5421819A (en) * 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5549644A (en) * 1992-08-12 1996-08-27 Vidamed, Inc. Transurethral needle ablation device with cystoscope and method for treatment of the prostate
US5542916A (en) * 1992-08-12 1996-08-06 Vidamed, Inc. Dual-channel RF power delivery system
US5536240A (en) * 1992-08-12 1996-07-16 Vidamed, Inc. Medical probe device and method
US5435805A (en) * 1992-08-12 1995-07-25 Vidamed, Inc. Medical probe device with optical viewing capability
US5366490A (en) * 1992-08-12 1994-11-22 Vidamed, Inc. Medical probe device and method
US5531676A (en) * 1992-08-12 1996-07-02 Vidamed, Inc. Medical probe device and method
US5531677A (en) * 1992-08-12 1996-07-02 Vidamed, Inc. Steerable medical probe with stylets
US5514131A (en) * 1992-08-12 1996-05-07 Stuart D. Edwards Method for the ablation treatment of the uvula
US5470308A (en) * 1992-08-12 1995-11-28 Vidamed, Inc. Medical probe with biopsy stylet
US5484400A (en) * 1992-08-12 1996-01-16 Vidamed, Inc. Dual channel RF delivery system
US5309910A (en) * 1992-09-25 1994-05-10 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5313943A (en) * 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US5549108A (en) * 1992-09-25 1996-08-27 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5293869A (en) * 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5509419A (en) * 1992-09-25 1996-04-23 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5471982A (en) * 1992-09-29 1995-12-05 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5383876A (en) * 1992-11-13 1995-01-24 American Cardiac Ablation Co., Inc. Fluid cooled electrosurgical probe for cutting and cauterizing tissue
US5348554A (en) * 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5545161A (en) * 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US5423811A (en) * 1992-12-01 1995-06-13 Cardiac Pathways Corporation Method for RF ablation using cooled electrode
US5456662A (en) * 1993-02-02 1995-10-10 Edwards; Stuart D. Method for reducing snoring by RF ablation of the uvula
US5486161A (en) * 1993-02-02 1996-01-23 Zomed International Medical probe device and method
US5403311A (en) * 1993-03-29 1995-04-04 Boston Scientific Corporation Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue
US5520684A (en) * 1993-06-10 1996-05-28 Imran; Mir A. Transurethral radio frequency apparatus for ablation of the prostate gland and method
US5571154A (en) * 1993-07-19 1996-11-05 Hunan University Microwave deep-diathermy apparatus
US5545193A (en) * 1993-10-15 1996-08-13 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5433739A (en) * 1993-11-02 1995-07-18 Sluijter; Menno E. Method and apparatus for heating an intervertebral disc for relief of back pain
US5507743A (en) * 1993-11-08 1996-04-16 Zomed International Coiled RF electrode treatment apparatus
US5472441A (en) * 1993-11-08 1995-12-05 Zomed International Device for treating cancer and non-malignant tumors and methods
US5536267A (en) * 1993-11-08 1996-07-16 Zomed International Multiple electrode ablation apparatus
US5458597A (en) * 1993-11-08 1995-10-17 Zomed International Device for treating cancer and non-malignant tumors and methods
US5458596A (en) * 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5505730A (en) * 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US5558672A (en) * 1994-06-24 1996-09-24 Vidacare, Inc. Thin layer ablation apparatus
US5545171A (en) * 1994-09-22 1996-08-13 Vidamed, Inc. Anastomosis catheter
US5558673A (en) * 1994-09-30 1996-09-24 Vidamed, Inc. Medical probe device and method having a flexible resilient tape stylet
US5514130A (en) * 1994-10-11 1996-05-07 Dorsal Med International RF apparatus for controlled depth ablation of soft tissue
WO1996029946A1 (en) * 1995-03-24 1996-10-03 Board Of Regents Of The University Of Nebraska Apparatus for ablation of tissue masses
US5672173A (en) * 1995-08-15 1997-09-30 Rita Medical Systems, Inc. Multiple antenna ablation apparatus and method

Non-Patent Citations (55)

* Cited by examiner, † Cited by third party
Title
A. Granapragsam, "Therapeutic Effects of Sub-Mucous Diathermy of Inferior Tubinates, with Special Reference To Ethnic Groups in Malaya", The Medical Journal of Malaya, vol. 26, No. 4, (1972).
A. Granapragsam, Therapeutic Effects of Sub Mucous Diathermy of Inferior Tubinates, with Special Reference To Ethnic Groups in Malaya , The Medical Journal of Malaya, vol. 26, No. 4, (1972). *
A.S. Jones, et al., "Does Submucosal Diathermy to the Inferior Turbinates Reduce Nasal Resistance to Airflow in the Long Term?", The Jourrnal of Laryngology and Otology, vol. 10 101, pp. 448-451, (1987).
A.S. Jones, et al., "Predicting the Outcome of Submucosal Diatherymy to the Inferior Turbinates", Clin. Otolaryngol, pp. 41-44, (1989).
A.S. Jones, et al., "The Effect of Submucosal Diathermy to the Inferior Turbinates on Nasal Resistance to Airflow in Allergic and Vasomotor Rhinitis", Clin. Otolaryngol., 10, pp. 249-252 (1985).
A.S. Jones, et al., Does Submucosal Diathermy to the Inferior Turbinates Reduce Nasal Resistance to Airflow in the Long Term , The Jourrnal of Laryngology and Otology, vol. 10 101, pp. 448 451, (1987). *
A.S. Jones, et al., Predicting the Outcome of Submucosal Diatherymy to the Inferior Turbinates , Clin. Otolaryngol, pp. 41 44, (1989). *
A.S. Jones, et al., The Effect of Submucosal Diathermy to the Inferior Turbinates on Nasal Resistance to Airflow in Allergic and Vasomotor Rhinitis , Clin. Otolaryngol., 10, pp. 249 252 (1985). *
A.W. McCombe, et al, "A Comparison of Laser Cautery and Sub-Mucosal Diatherymy for Rhinitis", Clin. Otolaryngol, 17, pp. 297-299, (1992).
A.W. McCombe, et al, A Comparison of Laser Cautery and Sub Mucosal Diatherymy for Rhinitis , Clin. Otolaryngol, 17, pp. 297 299, (1992). *
Baldev K. Devgan, M.D., et al. "Submuscosal Diathermy of Inferior Turbinates", vol. 55, pp. 156-159, (1976).
Baldev K. Devgan, M.D., et al. Submuscosal Diathermy of Inferior Turbinates , vol. 55, pp. 156 159, (1976). *
C.J. Woodhead, F.R.C.S., et al., "Some Observations on Submucous Diathermy", The Journal of Laryngology and Otology, vol. 103, pp. 1047-1049, (1989).
C.J. Woodhead, F.R.C.S., et al., Some Observations on Submucous Diathermy , The Journal of Laryngology and Otology, vol. 103, pp. 1047 1049, (1989). *
Carol L. Wengraf, et al., "The Stuffy Nose" A Comparative Study of Two Common Methods of Treatment, Clin. Otolaryngol, 11, pp. 61-68, (1986).
Carol L. Wengraf, et al., The Stuffy Nose A Comparative Study of Two Common Methods of Treatment, Clin. Otolaryngol, 11, pp. 61 68, (1986). *
D.J. Premachandra F.R.C.S., et al., "How Safe is Submucosal Diathermy?", The Journal of Laryngology and Otology, vol. 104, pp. 408-409, (1990).
D.J. Premachandra F.R.C.S., et al., How Safe is Submucosal Diathermy , The Journal of Laryngology and Otology, vol. 104, pp. 408 409, (1990). *
Dr. Franz Nagelschmidt, F (1909) Munchener Medizinishe Wochenschrift, 56 2575. *
F.E. Neres, M.D., "Voltaic Turbinal Puncture For the Relief of Intumescent and Hypertrophic Rhinitis" Jour. A.M.A., vol. 69, (1907).
F.E. Neres, M.D., Voltaic Turbinal Puncture For the Relief of Intumescent and Hypertrophic Rhinitis Jour. A.M.A., vol. 69, (1907). *
G. Brun, et al., "Endometrial Resection For Metorrhagla" 45 Case Histories.
G. Brun, et al., Endometrial Resection For Metorrhagla 45 Case Histories. *
H. Lenders, et al., "How Can Vasomotor Rhinitis Be Influenced Surgically?", Laryngo-Rhino-Otol. vol. 69, pp. 246-254, 1990.
H. Lenders, et al., How Can Vasomotor Rhinitis Be Influenced Surgically , Laryngo Rhino Otol. vol. 69, pp. 246 254, 1990. *
H.O. Williams, F.R.C.S., et al., "Two Stage Turbinectomy: Sequestration of the Inferior Turbinate Following Submucosal Diathermy", The Journal of Laryngology and Otology, vol. 105, pp. 14-16, (1991).
H.O. Williams, F.R.C.S., et al., Two Stage Turbinectomy: Sequestration of the Inferior Turbinate Following Submucosal Diathermy , The Journal of Laryngology and Otology, vol. 105, pp. 14 16, (1991). *
Henry Horn, M.D., "The Treatment of Intumscent Rhintis by a Submucous Method", pp. 490-495.
Henry Horn, M.D., The Treatment of Intumscent Rhintis by a Submucous Method , pp. 490 495. *
J.A. Cook, "Laser Treatment of Rhinitis" One Year Follow Up, Clin. Otolaryngol, pp. 209-211, (1993).
J.A. Cook, Laser Treatment of Rhinitis One Year Follow Up, Clin. Otolaryngol, pp. 209 211, (1993). *
J.F. Simpson et al., "Submucosal Diathermy of the Inferior Turbinates", pp. 292-301.
J.F. Simpson et al., Submucosal Diathermy of the Inferior Turbinates , pp. 292 301. *
J.R.M. Moore, et al., "A Comparison of Cyrosurgery and Submucous Diatherymy in Vasomotor Rhinitis", The Journal of Laryngology and Otology, vol. 94, pp. 1411-1413, (1980).
J.R.M. Moore, et al., A Comparison of Cyrosurgery and Submucous Diatherymy in Vasomotor Rhinitis , The Journal of Laryngology and Otology, vol. 94, pp. 1411 1413, (1980). *
John R. Richardson, M.D., "Turbinate Treatment in Vasomotor Rhinitis", pp. 834-847.
John R. Richardson, M.D., Turbinate Treatment in Vasomotor Rhinitis , pp. 834 847. *
Joseph C. Beck, M.D., "Annals of Otology, Rhinology and Laryngology", Incorporating the Index of Othalaryngology, vol. 39, pp. 349-363, (1930).
Joseph C. Beck, M.D., Annals of Otology, Rhinology and Laryngology , Incorporating the Index of Othalaryngology, vol. 39, pp. 349 363, (1930). *
Lee M. Hurd, "Biopolar Electrode For Electrocoagulation of the Inferior Turbinate", Archives of Otolaryngology, p. 442, (1930).
Lee M. Hurd, Biopolar Electrode For Electrocoagulation of the Inferior Turbinate , Archives of Otolaryngology, p. 442, (1930). *
Lee Shahinian, M.D., "Chronic Vasomotor Rhinitis", A.M.A. Archives of Otolaryngology, vol. 57, No. 5, pp. 475-489, (1953).
Lee Shahinian, M.D., Chronic Vasomotor Rhinitis , A.M.A. Archives of Otolaryngology, vol. 57, No. 5, pp. 475 489, (1953). *
Maddough Talaat, et al., "Submucous Diathermy of the Interior Turbinates in Chronic Hypertrophic Rhinitis", The Journal of Layngology and Otology, vol. 101, pp. 542-460, (1987).
Maddough Talaat, et al., Submucous Diathermy of the Interior Turbinates in Chronic Hypertrophic Rhinitis , The Journal of Layngology and Otology, vol. 101, pp. 542 460, (1987). *
Martin Jourdan, et al, "Diathermy and Cautery Equipment", British Journal of Hospital Medicine, pp. 89-92, (1981).
Martin Jourdan, et al, Diathermy and Cautery Equipment , British Journal of Hospital Medicine, pp. 89 92, (1981). *
N. Murata, et al., Submucosal Dissection of the Esophagus: A Case Report, Endoscopy, vol. 23, pp. 95 97, (1991). *
N. Murata, et al., Submucosal Dissection of the Esophagus: A Case Report, Endoscopy, vol. 23, pp. 95-97, (1991).
N.P. Warnick Brown, et al., Turbinate Surgery: How Effective is it , A Long Term Assessment, ORL 49:, pp. 314 320, (1987). *
N.P. Warnick-Brown, et al., "Turbinate Surgery: How Effective is it?", A Long-Term Assessment, ORL 49:, pp. 314-320, (1987).
Norman P. Von Haacke, et al., "Submucosal Dithermy of the Inferior Tubinate and the Congested Nose.", ORL 47, pp. 189-193, (1985).
Norman P. Von Haacke, et al., Submucosal Dithermy of the Inferior Tubinate and the Congested Nose. , ORL 47, pp. 189 193, (1985). *
T. Sauerbruch,et al., "Lymphangioma of the Duodenum", Endocscopy, vol. 9, pp. 179-182, (1977).
T. Sauerbruch,et al., Lymphangioma of the Duodenum , Endocscopy, vol. 9, pp. 179 182, (1977). *

Cited By (217)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6363937B1 (en) 1995-06-07 2002-04-02 Arthrocare Corporation System and methods for electrosurgical treatment of the digestive system
US6053172A (en) 1995-06-07 2000-04-25 Arthrocare Corporation Systems and methods for electrosurgical sinus surgery
US6063079A (en) 1995-06-07 2000-05-16 Arthrocare Corporation Methods for electrosurgical treatment of turbinates
US6086585A (en) 1995-06-07 2000-07-11 Arthrocare Corporation System and methods for electrosurgical treatment of sleep obstructive disorders
US6109268A (en) 1995-06-07 2000-08-29 Arthrocare Corporation Systems and methods for electrosurgical endoscopic sinus surgery
US6159208A (en) 1995-06-07 2000-12-12 Arthocare Corporation System and methods for electrosurgical treatment of obstructive sleep disorders
US6203542B1 (en) 1995-06-07 2001-03-20 Arthrocare Corporation Method for electrosurgical treatment of submucosal tissue
US6659106B1 (en) 1995-06-07 2003-12-09 Arthrocare Corporation System and methods for electrosurgical treatment of turbinates
US6544261B2 (en) 1995-06-07 2003-04-08 Arthrocare Corporation Systems and methods for electrosurgical treatment of submucosal tissue
US6432103B1 (en) 1995-06-07 2002-08-13 Arthrocare Corporation System for electrosurgical treatment of submucosal tissue
US5974343A (en) * 1996-01-12 1999-10-26 Bruker Sa Probe, particulary a urethral probe, for heating of tissues by microwave and for the measurement of temperature by radiometry
US6488673B1 (en) 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US8944071B2 (en) 1997-04-07 2015-02-03 Asthmatx, Inc. Method for treating an asthma attack
US6299633B1 (en) 1997-04-07 2001-10-09 Broncus Technologies, Inc. Bronchial stenter
US9956023B2 (en) 1997-04-07 2018-05-01 Boston Scientific Scimed, Inc. System for treating a lung
US6411852B1 (en) 1997-04-07 2002-06-25 Broncus Technologies, Inc. Modification of airways by application of energy
US10058370B2 (en) 1997-04-07 2018-08-28 Boston Scientific Scimed, Inc. Method for treating a lung
US6283989B1 (en) 1997-04-07 2001-09-04 Broncus Technolgies, Inc. Method of treating a bronchial tube with a bronchial stenter having diametrically adjustable electrodes
US7938123B2 (en) 1997-04-07 2011-05-10 Asthmatx, Inc. Modification of airways by application of cryo energy
US6283988B1 (en) 1997-04-07 2001-09-04 Broncus Technologies, Inc. Bronchial stenter having expandable electrodes
US9027564B2 (en) 1997-04-07 2015-05-12 Asthmatx, Inc. Method for treating a lung
US6634363B1 (en) 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US6273907B1 (en) 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
US11033317B2 (en) 1997-04-07 2021-06-15 Boston Scientific Scimed, Inc. Methods for treating a lung
US8161978B2 (en) 1997-04-07 2012-04-24 Asthmatx, Inc. Methods for treating asthma by damaging nerve tissue
US6200333B1 (en) 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US8267094B2 (en) 1997-04-07 2012-09-18 Asthmatx, Inc. Modification of airways by application of ultrasound energy
US8640711B2 (en) 1997-04-07 2014-02-04 Asthmatx, Inc. Method for treating an asthma attack
US7770584B2 (en) 1997-04-07 2010-08-10 Asthmatx, Inc. Modification of airways by application of microwave energy
US7740017B2 (en) 1997-04-07 2010-06-22 Asthmatx, Inc. Method for treating an asthma attack
US8584681B2 (en) 1998-01-07 2013-11-19 Asthmatx, Inc. Method for treating an asthma attack
US9789331B2 (en) 1998-01-07 2017-10-17 Boston Scientific Scimed, Inc. Methods of treating a lung
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US8464723B2 (en) 1998-06-10 2013-06-18 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US8534291B2 (en) 1998-06-10 2013-09-17 Asthmatx, Inc. Methods of treating inflammation in airways
US8443810B2 (en) 1998-06-10 2013-05-21 Asthmatx, Inc. Methods of reducing mucus in airways
US8733367B2 (en) 1998-06-10 2014-05-27 Asthmatx, Inc. Methods of treating inflammation in airways
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US6936046B2 (en) 2000-01-19 2005-08-30 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US10335280B2 (en) 2000-01-19 2019-07-02 Medtronic, Inc. Method for ablating target tissue of a patient
US6413254B1 (en) 2000-01-19 2002-07-02 Medtronic Xomed, Inc. Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6361531B1 (en) 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
US10278766B2 (en) 2000-03-27 2019-05-07 Boston Scientific Scimed, Inc. Methods for treating airways
US8459268B2 (en) 2000-03-27 2013-06-11 Asthmatx, Inc. Methods for treating airways
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US10561458B2 (en) 2000-03-27 2020-02-18 Boston Scientific Scimed, Inc. Methods for treating airways
US9358024B2 (en) 2000-03-27 2016-06-07 Asthmatx, Inc. Methods for treating airways
US8257413B2 (en) 2000-10-17 2012-09-04 Asthmatx, Inc. Modification of airways by application of energy
US9931163B2 (en) 2000-10-17 2018-04-03 Boston Scientific Scimed, Inc. Energy delivery devices
US7837679B2 (en) 2000-10-17 2010-11-23 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US8465486B2 (en) 2000-10-17 2013-06-18 Asthmatx, Inc. Modification of airways by application of energy
US8888769B2 (en) 2000-10-17 2014-11-18 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US7854734B2 (en) 2000-10-17 2010-12-21 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US9033976B2 (en) 2000-10-17 2015-05-19 Asthmatx, Inc. Modification of airways by application of energy
US10016592B2 (en) 2001-10-17 2018-07-10 Boston Scientific Scimed, Inc. Control system and process for application of energy to airway walls and other mediums
US10953170B2 (en) 2003-05-13 2021-03-23 Nuvaira, Inc. Apparatus for treating asthma using neurotoxin
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US7892230B2 (en) 2004-06-24 2011-02-22 Arthrocare Corporation Electrosurgical device having planar vertical electrode and related methods
US10398502B2 (en) 2004-11-05 2019-09-03 Boston Scientific Scimed, Inc. Energy delivery devices and methods
US7853331B2 (en) 2004-11-05 2010-12-14 Asthmatx, Inc. Medical device with procedure improvement features
US8480667B2 (en) 2004-11-05 2013-07-09 Asthmatx, Inc. Medical device with procedure improvement features
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
US10076380B2 (en) 2004-11-05 2018-09-18 Boston Scientific Scimed, Inc. Energy delivery devices and methods
US8920413B2 (en) 2004-11-12 2014-12-30 Asthmatx, Inc. Energy delivery devices and methods
US20060122587A1 (en) * 2004-11-17 2006-06-08 Shiva Sharareh Apparatus for real time evaluation of tissue ablation
US20060229515A1 (en) * 2004-11-17 2006-10-12 The Regents Of The University Of California Fiber optic evaluation of tissue modification
US10413188B2 (en) 2004-11-17 2019-09-17 Lawrence Livermore National Security, Llc Assessment of tissue or lesion depth using temporally resolved light scattering spectroscopy
US20070244529A1 (en) * 2006-04-18 2007-10-18 Zoom Therapeutics, Inc. Apparatus and methods for treatment of nasal tissue
US20080027520A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Laser treatment of tissue
US20080027423A1 (en) * 2006-07-25 2008-01-31 Zoom Therapeutics, Inc. Systems for treatment of nasal tissue
US7931647B2 (en) 2006-10-20 2011-04-26 Asthmatx, Inc. Method of delivering energy to a lung airway using markers
US11478299B2 (en) 2007-07-12 2022-10-25 Boston Scientific Scimed, Inc. Systems and methods for delivering energy to passageways in a patient
US8235983B2 (en) 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US10368941B2 (en) 2007-07-12 2019-08-06 Boston Scientific Scimed, Inc. Systems and methods for delivering energy to passageways in a patient
US20090124958A1 (en) * 2007-09-28 2009-05-14 Li Kasey K Device and methods for treatment of tissue
US8430920B2 (en) 2007-09-28 2013-04-30 Kasey K. LI Device and methods for treatment of tissue
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US11058879B2 (en) 2008-02-15 2021-07-13 Nuvaira, Inc. System and method for bronchial dilation
US8489192B1 (en) 2008-02-15 2013-07-16 Holaira, Inc. System and method for bronchial dilation
US8731672B2 (en) 2008-02-15 2014-05-20 Holaira, Inc. System and method for bronchial dilation
US9125643B2 (en) 2008-02-15 2015-09-08 Holaira, Inc. System and method for bronchial dilation
US8808280B2 (en) 2008-05-09 2014-08-19 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US9668809B2 (en) 2008-05-09 2017-06-06 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961507B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US10149714B2 (en) 2008-05-09 2018-12-11 Nuvaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8821489B2 (en) 2008-05-09 2014-09-02 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8777943B2 (en) 2009-10-27 2014-07-15 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9649153B2 (en) 2009-10-27 2017-05-16 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9931162B2 (en) 2009-10-27 2018-04-03 Nuvaira, Inc. Delivery devices with coolable energy emitting assemblies
US9005195B2 (en) 2009-10-27 2015-04-14 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9675412B2 (en) 2009-10-27 2017-06-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9017324B2 (en) 2009-10-27 2015-04-28 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US11389233B2 (en) 2009-11-11 2022-07-19 Nuvaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US10610283B2 (en) 2009-11-11 2020-04-07 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9649154B2 (en) 2009-11-11 2017-05-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US11712283B2 (en) 2009-11-11 2023-08-01 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US10448992B2 (en) 2010-10-22 2019-10-22 Arthrocare Corporation Electrosurgical system with device specific operational parameters
US8747401B2 (en) 2011-01-20 2014-06-10 Arthrocare Corporation Systems and methods for turbinate reduction
US9168082B2 (en) 2011-02-09 2015-10-27 Arthrocare Corporation Fine dissection electrosurgical device
US9271784B2 (en) 2011-02-09 2016-03-01 Arthrocare Corporation Fine dissection electrosurgical device
US9011428B2 (en) 2011-03-02 2015-04-21 Arthrocare Corporation Electrosurgical device with internal digestor electrode
US10470814B2 (en) 2011-06-14 2019-11-12 Aerin Medical, Inc. Pressure sensitive tissue treatment device
US11510722B2 (en) 2011-06-14 2022-11-29 Aerin Medical Inc. Pressure sensitive tissue treatment device
US11759222B2 (en) 2011-06-14 2023-09-19 Aerin Medical Inc. Methods and devices to treat nasal airways
US9433463B2 (en) 2011-06-14 2016-09-06 Aerin Medical, Inc. Devices to treat nasal airways
US9415194B2 (en) 2011-06-14 2016-08-16 Aerin Medical Inc. Post nasal drip treatment
US9687296B2 (en) 2011-06-14 2017-06-27 Aerin Medical Inc. Devices to treat nasal airways
US10779873B2 (en) 2011-06-14 2020-09-22 Aerin Medical, Inc. Methods of treating nasal airways
US9486278B2 (en) 2011-06-14 2016-11-08 Aerin Medical Inc. Methods and devices to treat nasal airways
US10932853B2 (en) 2011-06-14 2021-03-02 Aerin Medical, Inc. Methods of treating nasal airways
US9788886B2 (en) 2011-06-14 2017-10-17 Aerin Medical Inc. Methods and devices to treat nasal airways
US9801752B2 (en) 2011-06-14 2017-10-31 Aerin Medical, Inc. Post nasal drip treatment
US10485603B2 (en) 2011-06-14 2019-11-26 Aerin Medical, Inc. Methods and devices to treat nasal airways
US9888957B2 (en) 2011-06-14 2018-02-13 Aerin Medical Inc. Pressure sensitive tissue treatment device
US9913682B2 (en) 2011-06-14 2018-03-13 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10398489B2 (en) 2011-06-14 2019-09-03 Aerin Medical, Inc. Methods of treating nasal airways with radiofrequency energy
US8936594B2 (en) 2011-06-14 2015-01-20 Aerin Medical Inc. Methods and devices to treat nasal airways
US9943361B2 (en) 2011-06-14 2018-04-17 Aerin Medical Inc. Treating upper airway nerve tissue
US10456186B1 (en) 2011-06-14 2019-10-29 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10456185B2 (en) 2011-06-14 2019-10-29 Aerin Medical, Inc. Methods and devices to treat nasal airways
US9452010B2 (en) 2011-06-14 2016-09-27 Aerin Medical, Inc. Methods and devices to treat airways
US9526571B2 (en) 2011-06-14 2016-12-27 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10028780B2 (en) 2011-06-14 2018-07-24 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11766286B2 (en) 2011-06-14 2023-09-26 Aerin Medical Inc. Methods and devices to treat nasal airways
US11801084B2 (en) 2011-06-14 2023-10-31 Aerin Medical Inc. Methods and devices to treat nasal airways
US9237924B2 (en) 2011-06-14 2016-01-19 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11033318B2 (en) 2011-06-14 2021-06-15 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11457971B2 (en) 2011-06-14 2022-10-04 Aerin Medical Inc. Methods and devices to treat nasal airways
US10722282B2 (en) 2011-06-14 2020-07-28 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11304746B2 (en) 2011-06-14 2022-04-19 Aerin Medical Inc. Method of treating airway tissue to reduce mucus secretion
US10265115B2 (en) 2011-06-14 2019-04-23 Aerin Medical, Inc. Methods and devices to treat nasal airways
US9179967B2 (en) 2011-06-14 2015-11-10 Aerin Medical, Inc. Devices to treat nasal airways
US11241271B2 (en) 2011-06-14 2022-02-08 Aerin Medical Inc. Methods of treating nasal airways
US10335221B2 (en) 2011-06-14 2019-07-02 Aerin Medical, Inc. Methods and devices to treat nasal airways
US9179964B2 (en) 2011-06-14 2015-11-10 Aerin Medical, Inc. Methods and devices to treat nasal airways
US11832876B2 (en) 2011-06-14 2023-12-05 Aerin Medical Inc. Treating upper airway nerve tissue
US10376300B2 (en) 2011-06-14 2019-08-13 Aerin Medical, Inc. Methods and devices to treat nasal airways
US10631925B2 (en) 2011-06-14 2020-04-28 Aerin Medical, Inc. Treating upper airway nerve tissue
US9072597B2 (en) 2011-06-14 2015-07-07 Aerin Medical Inc. Methods and devices to treat nasal airways
US9788882B2 (en) 2011-09-08 2017-10-17 Arthrocare Corporation Plasma bipolar forceps
US9408662B2 (en) 2012-05-07 2016-08-09 Cook Medical Technologies Llc Sphincterotome having expandable tines
US9770293B2 (en) 2012-06-04 2017-09-26 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
US8986301B2 (en) 2012-06-13 2015-03-24 Aerin Medical Inc. Methods and devices to treat nasal airways
US9592086B2 (en) 2012-07-24 2017-03-14 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
US9572619B2 (en) 2012-11-02 2017-02-21 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9272132B2 (en) 2012-11-02 2016-03-01 Boston Scientific Scimed, Inc. Medical device for treating airways and related methods of use
US9974609B2 (en) 2012-11-05 2018-05-22 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US10492859B2 (en) 2012-11-05 2019-12-03 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9283374B2 (en) 2012-11-05 2016-03-15 Boston Scientific Scimed, Inc. Devices and methods for delivering energy to body lumens
US9364277B2 (en) 2012-12-13 2016-06-14 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9204921B2 (en) 2012-12-13 2015-12-08 Cook Medical Technologies Llc RF energy controller and method for electrosurgical medical devices
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9649144B2 (en) 2013-01-17 2017-05-16 Arthrocare Corporation Systems and methods for turbinate reduction
US9254166B2 (en) 2013-01-17 2016-02-09 Arthrocare Corporation Systems and methods for turbinate reduction
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
US10478247B2 (en) 2013-08-09 2019-11-19 Boston Scientific Scimed, Inc. Expandable catheter and related methods of manufacture and use
US11801090B2 (en) 2013-08-09 2023-10-31 Boston Scientific Scimed, Inc. Expandable catheter and related methods of manufacture and use
US10603059B2 (en) 2013-09-13 2020-03-31 Aerin Medical Inc. Hyaline cartilage shaping
US10512498B2 (en) 2013-09-30 2019-12-24 Arrinex, Inc. Apparatus and methods for treating rhinitis
US10307200B2 (en) 2013-09-30 2019-06-04 Arrinex, Inc. Apparatus and methods for treating rhinitis
US10448985B2 (en) 2013-09-30 2019-10-22 Arrinex, Inc. Apparatus and methods for treating rhinitis
US10470837B2 (en) 2014-07-25 2019-11-12 Arrinex, Inc. Apparatus and method for treating rhinitis
US20180271612A1 (en) * 2014-07-25 2018-09-27 Arrinex, Inc. Apparatus and Method for Treating Rhinitis
US10159538B2 (en) * 2014-07-25 2018-12-25 Arrinex, Inc. Apparatus and method for treating rhinitis
US10231779B2 (en) 2014-11-19 2019-03-19 Epix Therapeutics, Inc. Ablation catheter with high-resolution electrode assembly
US9517103B2 (en) 2014-11-19 2016-12-13 Advanced Cardiac Therapeutics, Inc. Medical instruments with multiple temperature sensors
US11701171B2 (en) 2014-11-19 2023-07-18 Epix Therapeutics, Inc. Methods of removing heat from an electrode using thermal shunting
US10166062B2 (en) 2014-11-19 2019-01-01 Epix Therapeutics, Inc. High-resolution mapping of tissue with pacing
US10383686B2 (en) 2014-11-19 2019-08-20 Epix Therapeutics, Inc. Ablation systems with multiple temperature sensors
US9510905B2 (en) 2014-11-19 2016-12-06 Advanced Cardiac Therapeutics, Inc. Systems and methods for high-resolution mapping of tissue
US10499983B2 (en) 2014-11-19 2019-12-10 Epix Therapeutics, Inc. Ablation systems and methods using heat shunt networks
US9592092B2 (en) 2014-11-19 2017-03-14 Advanced Cardiac Therapeutics, Inc. Orientation determination based on temperature measurements
US9522037B2 (en) 2014-11-19 2016-12-20 Advanced Cardiac Therapeutics, Inc. Treatment adjustment based on temperatures from multiple temperature sensors
US10413212B2 (en) 2014-11-19 2019-09-17 Epix Therapeutics, Inc. Methods and systems for enhanced mapping of tissue
US11534227B2 (en) 2014-11-19 2022-12-27 Epix Therapeutics, Inc. High-resolution mapping of tissue with pacing
US10660701B2 (en) 2014-11-19 2020-05-26 Epix Therapeutics, Inc. Methods of removing heat from an electrode using thermal shunting
US11642167B2 (en) 2014-11-19 2023-05-09 Epix Therapeutics, Inc. Electrode assembly with thermal shunt member
US11135009B2 (en) 2014-11-19 2021-10-05 Epix Therapeutics, Inc. Electrode assembly with thermal shunt member
US9522036B2 (en) 2014-11-19 2016-12-20 Advanced Cardiac Therapeutics, Inc. Ablation devices, systems and methods of using a high-resolution electrode assembly
US10675081B2 (en) 2015-03-25 2020-06-09 Epix Therapeutics, Inc. Contact sensing systems and methods
US11576714B2 (en) 2015-03-25 2023-02-14 Epix Therapeutics, Inc. Contact sensing systems and methods
US9636164B2 (en) 2015-03-25 2017-05-02 Advanced Cardiac Therapeutics, Inc. Contact sensing systems and methods
US11771497B2 (en) 2015-05-12 2023-10-03 National University Of Ireland, Galway Devices for therapeutic nasal neuromodulation and associated methods and systems
US10864035B2 (en) 2016-03-04 2020-12-15 Aerin Medical, Inc. Eustachian tube modification
US11179197B2 (en) 2016-03-15 2021-11-23 Epix Therapeutics, Inc. Methods of determining catheter orientation
US11389230B2 (en) 2016-03-15 2022-07-19 Epix Therapeutics, Inc. Systems for determining catheter orientation
US9993178B2 (en) 2016-03-15 2018-06-12 Epix Therapeutics, Inc. Methods of determining catheter orientation
US11116566B2 (en) 2016-12-22 2021-09-14 Aerin Medical, Inc. Soft palate treatment
US11806071B2 (en) 2016-12-22 2023-11-07 Aerin Medical Inc. Soft palate treatment
US10888373B2 (en) 2017-04-27 2021-01-12 Epix Therapeutics, Inc. Contact assessment between an ablation catheter and tissue
US11617618B2 (en) 2017-04-27 2023-04-04 Epix Therapeutics, Inc. Contact assessment between an ablation catheter and tissue
US10893903B2 (en) 2017-04-27 2021-01-19 Epix Therapeutics, Inc. Medical instruments having contact assessment features
US11278356B2 (en) 2017-04-28 2022-03-22 Arrinex, Inc. Systems and methods for locating blood vessels in the treatment of rhinitis
USD946150S1 (en) 2017-05-01 2022-03-15 Aerin Medical Inc. Nasal airway medical instrument
USD946149S1 (en) 2017-05-01 2022-03-15 Aerin Medical Inc. Nasal airway medical instrument
USD880694S1 (en) 2017-05-01 2020-04-07 Aerin Medical, Inc. Nasal airway medical instrument
US11096738B2 (en) 2017-05-05 2021-08-24 Aerin Medical, Inc. Treatment of spinal tissue
US20190374666A1 (en) * 2018-06-07 2019-12-12 Dickey Arndt Systems and method for decontaminating a tube
US10918751B2 (en) 2018-06-07 2021-02-16 Dickey Arndt Systems and method for decontaminating a tube
USD881904S1 (en) 2018-10-31 2020-04-21 Aerin Medical Inc. Display screen with animated graphical user interface
USD902412S1 (en) 2018-10-31 2020-11-17 Aerin Medical, Inc. Electrosurgery console
US11701167B2 (en) 2018-12-11 2023-07-18 Neurent Medical Limited Systems and methods for therapeutic nasal neuromodulation
US11684414B2 (en) 2018-12-11 2023-06-27 Neurent Medical Limited Systems and methods for therapeutic nasal neuromodulation
US11666378B2 (en) * 2018-12-11 2023-06-06 Neurent Medical Limited Systems and methods for therapeutic nasal neuromodulation
US20200179681A1 (en) * 2018-12-11 2020-06-11 Neurent Medical Limited Systems and methods for therapeutic nasal neuromodulation
EP4069119A4 (en) * 2019-12-07 2023-12-13 APYX Medical Corporation Devices, systems and methods for calculating the amount of energy delivered to tissue during an electrosurgical treatment
US11883091B2 (en) 2020-04-09 2024-01-30 Neurent Medical Limited Systems and methods for improving sleep with therapeutic nasal treatment
US11896818B2 (en) 2020-04-09 2024-02-13 Neurent Medical Limited Systems and methods for therapeutic nasal treatment

Similar Documents

Publication Publication Date Title
US5827277A (en) Minimally invasive apparatus for internal ablation of turbinates
US5843077A (en) Minimally invasive apparatus for internal ablation of turbinates with surface cooling
US5823197A (en) Method for internal ablation of turbinates
US5800429A (en) Noninvasive apparatus for ablating turbinates
WO1997043971A2 (en) Method and apparatus for ablating turbinates
AU718288B2 (en) Apparatus for cosmetically remodeling a body structure
US5738114A (en) Method and apparatus for treatment of air way obstructions
US5707349A (en) Method for treatment of air way obstructions
US5728094A (en) Method and apparatus for treatment of air way obstructions
US5817049A (en) Method for treatment of airway obstructions
US5820580A (en) Method for ablating interior sections of the tongue
US5879349A (en) Apparatus for treatment of air way obstructions
US5843026A (en) BPH ablation method and apparatus
US5730719A (en) Method and apparatus for cosmetically remodeling a body structure
WO1999003412A1 (en) Apparatus for electrosurgical treatment of air ways obstructions
US20010051783A1 (en) Method and apparatus for treatment of air way obstructions
WO1997041785A2 (en) Apparatus for cosmetically remodeling a body structure
WO1997006741A2 (en) Apparatus for cosmetically remodeling a body structure
WO1997043973A1 (en) Method for ablating interior sections of the tongue
WO1997030645A1 (en) Apparatus and method for treating airway insufficiency in the laringeal/oral cavity region by electromagnetic energy
WO1997043969A1 (en) Apparatus for cosmetically remodeling a body structure
WO1999003411A1 (en) Method and apparatus for treatment of air way obstructions

Legal Events

Date Code Title Description
AS Assignment

Owner name: SOMNUS MEDICAL TECHNOLOGIES, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EDWARDS, STUART D.;REEL/FRAME:008622/0705

Effective date: 19970506

CC Certificate of correction
FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20021027